

ACCESSION NUMBER:		0001165527-17-000047
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		50
CONFORMED PERIOD OF REPORT:	20161130
FILED AS OF DATE:		20170228
DATE AS OF CHANGE:		20170228
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Trident Brands Inc
		CENTRAL INDEX KEY:			0001421907
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				261367322
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1130
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53707
		FILM NUMBER:		17649280
	BUSINESS ADDRESS:	
		STREET 1:		200 SOUTH EXECUTIVE DRIVE
 SUITE 101
		CITY:			BROOKFIELD
		STATE:			WI
		ZIP:			53005
		BUSINESS PHONE:		262-789-6689
	MAIL ADDRESS:	
		STREET 1:		200 SOUTH EXECUTIVE DRIVE
 SUITE 101
		CITY:			BROOKFIELD
		STATE:			WI
		ZIP:			53005
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sandfield Ventures Corp.
		DATE OF NAME CHANGE:	20071220










    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing

















































































 as defined in Rule&#160;405 of the Securities Act.&#160;Yes&#160;




 and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;Yes&#160;


 if any
 every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes



 and will not be contained
 to the best of registrant&#8217;s knowledge
 in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form&#160;10-K or any amendment to this Form&#160;10-K.&#160;


 an accelerated filer
 a non-accelerated filer
 or a smaller reporting company. See the definitions of &#8220;large accelerated filer



































 2017
 the registrant had 31
000
000 shares of common stock issued and outstanding.&#160; No market value has been computed based upon the fact that no active trading market had been established as of February 28


































































































































































































































































































































































 all references in this Annual Report on Form 10-K for the fiscal year ended November 30
 2016 (&#8220;Form 10-K&#8221;) to the &#8220;Company&#8221;
 &#8220;we&#8221;
 &#8220;us&#8221;
 &#8220;our&#8221;
 &#8220;Trident&#8221; and &#8220;Trident Brands&#8221; or similar words and phrases are to Trident Brands Incorporated . and its subsidiaries




 all currency amounts are expressed in thousands of United States (&#8220;U.S.&#8221;) dollars (&#8220;$&#8221;)
 except per share data
 unless otherwise stated.&#160; Amounts expressed in other than U.S. dollars are noted accordingly.&#160; For example







 forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as &#8220;anticipate&#8221;
 &#8220;estimate&#8221;
 &#8220;intend&#8221;
 &#8220;project&#8221;
 &#8220;potential&#8221;
 &#8220;continue&#8221;
 &#8220;believe&#8221;
 &#8220;expect&#8221;
 &#8220;could&#8221;
 &#8220;would&#8221;
 &#8220;should&#8221;
 &#8220;might&#8221;
 &#8220;plan&#8221;
 &#8220;will&#8221;
 &#8220;may&#8221;
 &#8220;predict&#8221;
 the negatives of such terms
 and words and phrases of similar impact and include
 but are not limited to references to expected increases in revenues and margins
 growth opportunities
 the success of new product launches and line extensions
 our ability to finance our business
 potential strategic investments
 business strategies
 competitive strengths
 goals
 references to key markets where we operate and the market for our securities.&#160; These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on certain assumptions and analyses we make in light of our experience and our interpretation of current conditions
 historical trends and expected future developments




 there are or will be important factors that could cause our actual results to differ materially from our expectations and predictions. We believe these factors include
 but are not limited to























 accumulated deficit and insufficient cash resources to meet our business objectives
























































































































































































 some of our products could fail in the marketplace
 which could negatively impact our revenues


























 if these third parties fail to reliably supply products to us at required levels of quality and which are manufactured in compliance with applicable laws


























































































 which could lead to wide fluctuations in our share price. Our shareholders may be unable to sell their common stock at or above their purchase price if at all

















































 officers and employees under Nevada law and the existence of indemnification rights of our directors
 officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors




















 you should read our risk factors in Item 1A
 Risk Factors























 2007.&#160; The Company was initially formed to engage in the acquisition
 exploration and development of natural resource properties




 and functional food ingredients under the Oceans Omega brand. The Company also provides a range of private label nutritional and supplement products to retailers. These products are focused on the fast growing supplements and nutritional product and heart and brain health categories
 supported by an established contract manufacturing
 supply chain and research and development infrastructure
 and a solid and proactive management team















 Sports Nutrition Product Inc. is 100% owned by Trident Brands and holds the license to market and sell products in the nutritional foods and supplements categories under the Everlast&#174; brand




 Suite 101
 Brookfield
 Wisconsin




000
000 common shares with a par value of $0.001 per share. 31
000
000 common shares were issued and outstanding as of November 30
 2016 and 31
000
000 as of February 28





















 2013 the Board of Directors approved an agreement and plan of merger with a wholly-owned subsidiary called Trident Brands Incorporated.&#160; At that point we changed our name from Sandfield Ventures Corp. to Trident Brands Incorporated and Mark Holcombe assumed the role of Chief Executive Officer
 President



 on July 9
 2013
 our Board of Directors approved a resolution to affect a 4 for 1 forward stock split. Upon effect of the forward split
 our authorized capital increased from 75
000
000 to 300
000
000 shares of common stock and correspondingly
 our issued and outstanding shares of common stock increased from 7
000
000 to 28
000
000 shares of common stock



 2013
 our directors approved the adoption of our 2013 Stock Option Plan which permits us to issue up to 4
200
000 shares of our common stock to directors
 officers



 2013
 we signed a 15 year license agreement (including a ten year extension option) with Everlast&#174; World&#8217;s Boxing Headquarters Corp.
 International Brand Management &amp; Licensing



 2014
























 Chair of the Corporate Governance Committee













 Chief Financial Officer



















 President
 Secretary and Treasurer
 and was appointed as Chair of the Board of Directors and Chair of the Compensation Committee. Mr. Holcombe's resignation as Chief Executive Officer
 President
 Secretary and Treasurer was not the result of any disagreement with our Company regarding its operations
 policies



 2014
 we entered into a Product Development Agreement with Continental Ingredients Canada Inc. in support of our plan to commercialize nutritional supplements and functional food and beverage products for sales in North America.&#160; Under the Agreement
 we engaged Continental Ingredients on an exclusive basis to provide services for the development
 manufacturing and supply of our products for a period of five years commencing on May 5
 2014 and ending on May 4
 2019
 such term to renew automatically for a further 12 months unless either party delivered a written termination notice six months prior to the expiration of the initial term or renewal period.&#160; This agreement has subsequently been revised effective December 9



 2014



 2014
 we granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of our company pursuant to our 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted











125
000 stock options to our then President
 Chief Financial Officer
 Treasurer and Secretary













000 stock options to each of our directors
 Donald MacPhee
 Scott Chapman













000 stock options to our controller













000 stock options to each of our special advisors





















 2015
 we entered into a securities purchase agreement with a non-US institutional investor whereby we agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the Company's common stock. We&#160; received the funds from the transaction in two traunches
 $1
800
000 on February 5
 2015 and $500
000 on May 14
 2015.&#160; The convertible debentures are convertible into shares of the Company's common stock at an initial conversion price of $.71 per share
 for an aggregate of up to 3
239
437 shares. The debentures bear interest at 6% per annum



 2015
 we engaged Malone Bailey LLP as our new independent registered public accounting firm. On March 6
 2015
 we formally informed George Stewart
 CPA of their dismissal as the Company's independent registered public accounting firm. The reports of George Stewart
 CPA on the Company's financial statements as of and for the fiscal years ended November 30
 2014 and 2013 contained no adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty
 audit scope or accounting principle except to indicate that there was substantial doubt about the Company's ability to continue as a going concern.&#160; There had been no disagreements with George Stewart
 CPA on any matter of accounting principles or practices
 financial statement disclosure or auditing scope or procedure
 which disagreements if not resolved to the satisfaction of George Stewart



 2015
 we acquired
 through a licensing agreement with DSM Nutritional Products LLC (&#8220;DNP&#8221;)
 the exclusive global rights to Brain Armor&#174; dietary supplements
 a plant-based DHA supplement designed specifically for the needs of athletes.&#160; At the same time
 a wholly-owned subsidiary
 Brain Armor Incorporated was registered to hold the trademark license and all costs and revenue associated with commercial development of the Brain Armor&#174; brand. As per the agreement
 DNP shall be the sole source of the Company's omega-3 oil requirements which will be DNP's life's DHATM oil and will supply the soft gel capsules in finished form to us. In order to maintain exclusivity to the license
 we are required to meet certain targets with respect to product launches and sales volume.&#160; Also under the terms of the agreement we have the opportunity to exercise an option to purchase the Brain Armor(R) dietary supplement brand. The term of the Agreement and the license rights is for five (5) years and shall be subject to successive one (1) year automatic renewal periods



 2015
 we appointed Dr. Neilank K. Jha
 MD
 FRCS (C) as a Special Advisor to its Brain Armor&#174; subsidiary.&#160; On September 29
 2015 the Board of Directors of Brain Armor Inc. allotted 100
000 shares of common stock representing 10% of the issued and outstanding capital of Brain Armor Inc. to KONKUSSION Inc.
 a company controlled by Dr. Jha. Dr. Jha is a board certified Neurosurgeon FRCS(C) and a fellowship trained Spine Surgeon. Dr. Jha is one of North America's foremost concussion experts
 with published articles
 papers and book chapters



 2015
 we entered into a consulting agreement with Dr. Julian Bailes wherein Dr. Bailes has agreed to provide consulting services as a Special Advisor to our Company and/or our subsidiary
 Brain Armor Inc. for a period of 12 months.&#160;&#160;Pursuant to the consulting agreement
 we agreed to issue to Dr. Bailes 5% of the issued and outstanding shares of Brain Armor Inc. effective November 30
 2015.&#160; As a result
 our company now holds 85.5% of the issued and outstanding shares of Brain Armor Inc.&#160;&#160; Dr. Bailes is a nationally recognized leader in the field of neurosurgery and conducts research on the impact of brain injury on neurological function. Dr. Bailes is the Chairman of the Department of Neurosurgery at North Shore University Health System
 Co-Director of the North Shore Neurological Institute



 2015
 Michael Browne signed a service contract with the company to serve as Brand Director of Trident Brands Inc.&#160;&#160; At that time his stock options were amended from a total of 1
125
000 which were issued May 5
 2014 to 625
000.&#160;&#160; As a result
 total stock options outstanding as of November 30
 2015&#160;was 2
375

















 2015
 a Letter of Intent (&#8220;LOI&#8221;) was signed confirming the intention of Trident Brands Inc. and Continental Ingredients Canada Inc. to enter into negotiations regarding the acquisition by Trident of up to 43% of the voting securities of Continental with an option to acquire the balance of all remaining issued and outstanding voting securities at the time of the closing of the transaction.&#160; Approval of any subsequent agreement
 if any
 was subject to approval by a Special Committee of the Board
 and no deal was ever consummated in this regard. On September 1
 2016




 2015
 we entered into a revised Product Development Agreement (&#8220;PDA&#8221;) with Continental Ingredients Canada Inc. (&#8220;CIC&#8221;) pursuant to which we engaged CIC on an exclusive basis to provide services for the development
 manufacturing
 and supply of our Everlast Nutrition&#174; and Brain Armor&#8482; brand nutritional supplements
 and functional food and beverage products.&#160;&#160;CIC&#8217;s services will include research and development
 design
 ingredient sourcing
 production
 distribution
 and inventory management of our planned portfolio of branded products.&#160;&#160;In addition
 CIC will manage all third party suppliers and manufacturers
 and provide us with office space at their Oakville
 Ontario
 facility.&#160;&#160;The term of the PDA is for 5 years
 expiring on December 9
 2020.&#160;&#160;The term will renew automatically for successive 12 month periods unless terminated by either party with 6 months&#8217; notice.&#160;&#160;This PDA replaced our previous agreement with CIC dated May 5
 2016
 the PDA was further amended to clarify that while neither party to the agreement can assign its interests or obligations without the prior written consent of the other party



 2015
 Michael Browne resigned as President of our Company to focus on his Brand Director
 Chief Financial Officer
 Secretary and Treasurer responsibilities.&#160; Mr. Browne&#8217;s resignation was not the result of any disagreement with our Company regarding our operations
 policies




 effective December 15
 2015
 Donald MacPhee
 one of our board members




 2016
 we issued 3
000
000 common shares pursuant to a Deed of Assignment dated effective January 20
 2015 among our Company
 Oceans Omega LLC
 and the assignor 2298107 Ontario Inc.
 pursuant to which the assignor assigned to our Company the assignor&#8217;s non-exclusive rights to purchase
 market
 sell and distribute certain Omega 3 nutritional emulsions produced by Oceans Omega LLC to the food and beverage industries and exclusive rights to purchase
 market




 2016
 we entered into a Securities Purchase Agreement with one investor whereby we received proceeds of $250
000 in return for a $250
000 secured promissory note due 12 months from the issuance date
 bearing interest at the rate of 10% per annum
 and 125




 2016
 we entered into a Securities Purchase Agreement with CIC whereby we received proceeds of $200
000 in return for a $200
000 secured promissory note due 12 months from the issuance date
 bearing interest at the rate of 10% per annum
 and 100




 2016
 we entered into a Special Advisor Consulting Agreement with Bromley Consulting &amp; Advisory Inc. (Bromley Consulting) and Steve Bromley pursuant to which Bromley Consulting agreed to provide the services of Steve Bromley as a Special Advisor to the Company and as Chair of our Advisory Committee. The initial term of the Agreement was for one year and renewing automatically for successive one year periods unless terminated by either party with not less than 30 days' notice. In consideration of the engagement
 we have agreed to pay Bromley Consulting an annual retainer of $30
000 payable in monthly installments of $2
500 plus fees for additional services to be mutually agreed
 and we issued to Mr. Bromley 100
000 stock options under our 2013 Stock Option Plan
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&#160; Effective June 1
 2016 we issued to Mr. Bromley an additional 200
000 stock options under our 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options expire on June 1
 2021.&#160; Effective November 1
 2016 this Agreement was replaced by a Services Agreement whereby Steve Bromley would continue in his capacity as Chair of our Advisory Committee for a monthly fee of $1
000 plus the options previously granted on May 1
 2016
 terminable by either party at any time. The 200
000 stock options issued on June 1









 2016
 we entered into a Securities Purchase Agreement with a non-US institutional investor&#160;&#160; pursuant to which
 in consideration for proceeds of $4
100
000
 we issued a secured convertible promissory note in the amount of $4
100
000.&#160; Pursuant to the Securities Purchase Agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at our request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26
 2016.&#160; We intend to use the proceeds from the $4
100
000 secured promissory note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans. In consideration of each advance made by the investor pursuant to the Securities Purchase Agreement
 we will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note will be secured in first priority against the present and after acquired assets of the Company



 2016
 we entered into a Convertible Promissory Note Amendment Agreement with the same non-US institutional investor whereby we agreed to extend the maturity date and interest payable on $2
300
000 of senior secured convertible debentures which were initially funded on February 5
 2015 and on May 14
 2015.&#160; Under the terms of the amendment the maturity date of the notes were extended through September 30




 2016
 Karen Arsenault resigned from her role as Special Advisor to the Company.&#160; Ms. Arsenault was appointed as Special Advisor on May 5















 Chair of the Audit Committee and as President and Chief Executive Officer







































 our Director and Chair of the Corporate Governance Committee













 Chief Financial Officer





















 2017
 we entered into a Letter of Intent (the &#8220;LOI&#8221;) with The Activation Group
 Inc.
 an integrated marketing and advertising agency incorporated in Ontario
 Canada.&#160; Pursuant to the LOI
 we will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200
000 cash
 and $800
000 payable in common shares of Trident.&#160; The cash consideration is inclusive of a $50
000 deposit paid to The Activation Group upon execution of the LOI
 and $150
000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200
000 installments
 subject to the achievement of earnings targets.&#160; The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence





 on February 15
 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated















 supply chain
 product development and corporate finance. Our team has experience in developing and commercializing consumer products






















































































 we believe we are making progress against our goals and objectives
&#174; product lines are now in the market and generating revenues.&#160; We are also developing a full range of private label product offerings.&#160; The development of Oceans Omega as an ingredient for food and beverage products is ongoing
 and given the longer sales cycle for ingredients
 we expect to realize revenues in 2017 both through external customer product development and also internally via potential line extensions for both the E







































































































 we will seek to acquire positions in businesses to support our strategy through the use of common and/or preferred equity
 senior secured
 unsecured
 and convertible debt in organizations who meet our investment goals. Through our management and directors vast expertise in both the consumer branded segment and strategic investment experience









































































 with a 10 year extension option
 to market and sell products in the nutritional foods and supplements category under the Everlast&#174; brand. The US Dietary Supplement Segment continues to experience dynamic growth driven by favorable demographic trends
 increased media coverage of dietary issues and greater emphasis on preventive health/wellness practices in the healthcare industry






 we acquired
 through a licensing agreement
 the exclusive global rights to Brain Armor&#174;
&#160;a plant-based DHA supplement designed specifically for the needs of athletes. Brain Armor&#174; helps optimize cognitive and visual performance by supplying a meaningful amount of DHA
 an important Omega-3 shown to support brain
 eye and heart health. Brain Armor&#174; is powered by Life&#8217;s DHA&#174;






 market






(&#8220;CIC&#8221;) whereby they provide services for the development
 manufacturing
 and supply of our Everlast Nutrition&#174; and Brain Armor&#8482; brand nutritional supplements
 and functional food and beverage products.&#160;&#160;CIC&#8217;s services include research and development
 design
 ingredient sourcing
 production
 distribution
 and inventory management of our planned portfolio of branded products.&#160;&#160;In addition
 CIC manages all third party suppliers and manufacturers
 and provides us with office space at their Oakville
 Ontario
 facility.&#160;&#160;






 large and small
 competing for market share. The nutritional products market is one of the fastest growing markets in the world producing close to 32 billion dollars in revenue in 2012
 and is projected to double
 producing revenues exceeding 60 billion dollars by 2021 according to the Nutritional Business Journal. With the combination of high quality
 scientifically designed and cost competitive products
 and the equity in our brands







 supply chain and products are subject to a wide range of governmental regulations and policies in various regions where we operate
 including the U.S. and Canada.&#160; These laws
 regulations and policies are implemented
 as applicable in each jurisdiction
 on the national
 federal
 state













Patents
 Trademarks
 Franchises
 Concessions
 Royalty Agreements
 or Labor Contracts



 trademarks
 copyrights
 franchises or concessions as these are currently owned by our licensing partners.&#160; We will assess the need for any copyright



Human Resources
 Contract Service Providers
 Employees


We presently do not have pension
 health
 annuity
 insurance
 profit sharing or similar benefit plans; however
 we may adopt such plans in the future. Except for our stock option plan
 there are presently no personal benefits available to our officers and directors.






 including filing Form 10K annually and Form 10Q quarterly.&#160; In addition
 we will file Form 8K and other proxy and information statements from time to time as required.&#160; We do not intend to voluntarily file the above reports in the event that our obligation to file such reports is suspended under the Exchange Act.&#160; The public may read and copy any materials that we file with the Securities and Exchange Commission
 (SEC)
 at the SEC's Public Reference Room at 100 F Street NE
 Washington
 DC 20549.&#160; The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.&#160; The SEC maintains an Internet site (http://www.sec.gov) that contains reports
 proxy and information statements










 our business
 financial condition or results of operations could be harmed. In that case
 the trading price of our common stock could decline






We have yet to establish a history of profitable operations and
 as at November 30
 2016
 have an accumulated deficit of $6
936
102
since our inception on November 5
 2007.&#160; We have generated only nominal revenues since our inception and thus have incurred operating losses.&#160; Our profitability will require the successful commercialization and sales of our planned products at acceptable margins.&#160;We may not be able to successfully achieve any of these requirements or ever become profitable.







 we could lose existing customers and more importantly fail to win new and retain any future customers. In order to compete effectively in the food and nutritional products industry
 we must continually design
 develop implement and market new and/or enhanced products and strategies. Our future success will depend
 in part

































 operating and financial resources.&#160;To manage possible growth and change







 which cannot be guaranteed. Our operations will be subject to all the risks inherent in the uncertainties arising from the absence of a significant operating history. We may be unable profitably sell our food and nutritional products and thus operate on a profitable basis. Potential investors should be aware of the difficulties normally encountered by enterprises in the development stage. If our business plan is not successful
 and we are not able to operate profitably






 in part
 on obtaining and maintaining patent protection
 trade secret protection and regulatory protection of our technologies and products as well as successfully defending third-party challenges to such technologies and products. We will be able to protect our technologies and product from use by third parties only to the extent that valid and enforceable patents
 trade secrets or regulatory protection cover them and we have exclusive rights to use them. The ability of our licensors
 collaborators and suppliers to maintain their patent rights against third-party challenges to their validity




 and the patent situation outside the United States is even more uncertain. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. Accordingly



 especially where we do not believe patent protection is appropriate or obtainable. However
 trade secrets are difficult to protect. While we seek to protect confidential information
 in part
 through confidentiality agreements with our employees
 consultants and scientific and other advisors
 they may unintentionally or willfully disclose our information to competitors. Enforcing a claim against a third party related to the illegal acquisition and use of trade secrets can be expensive and time consuming
 and the outcome is often unpredictable. If we are not able to maintain patent or trade secret protection on our technologies and products
 then we may not be able to exclude competitors from developing or marketing competing products













 and we believe that there will continue to be
 significant litigation and demands for licenses in our industry regarding patent and other intellectual property rights. Although we anticipate having a valid defense to any allegation that our current products
 production methods and other activities infringe the valid and enforceable intellectual property rights of any third parties
 we cannot be certain that a third party will not challenge our position in the future. Other parties may own patent rights that we might infringe with our products or other activities
 and our competitors or other patent holders may assert that our products and the methods we employ are covered by their patents. These parties could bring claims against us that would cause us to incur substantial litigation expenses and
 if successful
 may require us to pay substantial damages. Some of our potential competitors may be better able to sustain the costs of complex patent litigation
 and depending on the circumstances
 we could be forced to stop or delay our research
 development












 which presently are based upon a combination of copyright
 trade secret and trademark laws



 the laws of foreign countries may provide inadequate protection of such intellectual property rights. We may need to bring legal claims to enforce or protect such intellectual property rights. Any litigation
 whether successful or unsuccessful
 could result in substantial costs and diversions of resources. In addition
 notwithstanding any rights we have secured in our intellectual property
 other persons may bring claims against us that we have infringed on their intellectual property rights
 including claims based upon the content we license from third parties or claims that our intellectual property right interests are not valid. Any claims against us
 with or without merit
 could be time consuming and costly to defend or litigate
 divert our attention and resources







 we expect to experience significant and rapid growth in the scope and complexity of our business. We will need to add resources to market our services
 manage operations
 handle sales and marketing efforts and perform finance and accounting functions. We will be required to hire a broad range of additional personnel in order to successfully advance our operations. This growth is likely to place a strain on our management and operational resources. The failure to develop and implement effective systems
 or to hire and retain sufficient personnel for the performance of all of the functions necessary to effectively service and manage our potential business
 or the failure to manage growth effectively

















 our products may quickly become obsolete and unmarketable. Our future success will depend on our ability to adapt to and anticipate market demands
 develop new products and enhance our current products on a timely and cost-effective basis. Further
 our products must remain competitive with those of other companies with substantially greater resources. We may experience technical or other difficulties that could delay or prevent the development
 introduction or marketing of new products or enhanced versions of existing products. Also











 some of our products could fail in the marketplace
 which could negatively impact our revenues




 including various prescription drugs
 which may rapidly capture a significant share of the market. These market segments include numerous manufacturers
 distributors
 marketers








 manufacturing
 packaging
 labeling
 distribution
 advertising
 licensing




 resulting in loss of revenues.&#160; We are subject to FDA rules for current good manufacturing practices
 or GMPs
 for the manufacture
 packing








 if these third parties fail to reliably supply products to us at required levels of quality and which are manufactured in compliance with applicable laws




&#160; reliably supply products to us at the levels of quality
 or the quantities
 we require
 and in compliance with applicable laws
 including under the FDA&#8217;s GMP regulations.&#160; Additionally
 while we are not presently aware of any current liquidity issues with our suppliers

















 we may be subjected to various product liability claims
 including that the products contain contaminants
 the products include inadequate instructions as to their uses
 or the products include inadequate warnings concerning side effects and interactions with other substances. It is possible that widespread product liability claims could increase our costs
 and adversely affect our revenues and operating income. Moreover
 liability claims arising from a serious adverse event may increase our costs through higher insurance premiums and deductibles







 and we generally do not have long-term agreements with or commitments from these customers for the purchase of products.&#160; We cannot provide assurance that our customers will maintain or increase their sales volumes or orders for the products supplied by us or that we will be able to maintain or add to our existing customer base.&#160; Decreases in our customers&#8217; sales volumes or orders for products supplied by us may have a material adverse effect on our business








 processing
 packaging and distribution of many of our products. &#160;The inability of any of these suppliers to deliver or perform for us in a timely or cost-effective manner could cause our operating costs to rise and our margins to fall. &#160;We must continuously monitor our inventory and product mix against forecasted demand or risk having inadequate supplies to meet consumer demand as well as having too much inventory that may reach its expiration date. &#160;If we are unable to manage our supply chain efficiently and ensure that our products are available to meet consumer demand








The stock markets have experienced significant price and trading volume fluctuations
 quotation system in which shares of our common stock are listed
 have been volatile in the past and have experienced sharp share price and trading volume changes. The trading price of our common stock is likely to be volatile and could fluctuate widely in response to many factors
 including the following
 some of which are beyond our control:


































































 as well as general economic and political conditions unrelated to our performance





















 including the fact that we are a small company in its development phase which is relatively unknown to stock analysts
 stock brokers
 institutional investors and others in the investment community who generate or influence sales volume. Even if we came to the attention of such persons
 those persons may be reluctant to follow
 purchase
 or recommend the purchase of shares of an unproven company such as ours until such time as we become more seasoned and viable. As a consequence
 there may be periods of several days or more when trading activity in our shares is minimal or non-existent
 as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous trades without an adverse effect on share price. We cannot be assured that a broader or more active public trading market for our common stock will develop or be sustained




 which could lead to wide fluctuations in our share price. Our shareholders may be unable to sell your common stock at or above your purchase price if at all




 according to SEC Release No. 34-29093
 the market for penny stock/over the counter stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level







 it would be contingent upon our revenues and earnings
 if any
 capital requirements
 and general financial condition. The payment of any common stock dividends will be within the discretion of our Board of Directors. We presently intend to retain all earnings to implement our business plan; accordingly













 and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. In the past
 plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may
 in the future




 officers and employees under Nevada law and the existence of indemnification rights of our directors
 officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors














 we are prepared to give such indemnification to our directors and officers to the extent provided for by Nevada law. We may also have contractual indemnification obligations under our employment agreements with our officers. The foregoing indemnification obligations could result in our company incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers
 which we may be unable to recoup. These provisions and resultant costs may also discourage our company from bringing a lawsuit against directors and officers for breaches of their fiduciary duties
 and may similarly discourage the filing of derivative litigation by our shareholders against our directors and officers even though such actions
 if successful






 we are subject to certain rules and regulations of federal
 state and financial market exchange entities charged with the protection of investors and the oversight of companies whose securities are publicly traded. These entities
 including the Public Company Accounting Oversight Board
 the SEC and FINRA
 have issued requirements and regulations and continue to develop additional regulations and requirements in response to corporate scandals and laws enacted by Congress
 most notably the Sarbanes-Oxley Act of 2002. Our efforts to comply with these regulations have resulted in
 and are likely to continue resulting in
 increased general and administrative expenses and diversion of management time and attention from revenue-generating activities to compliance activities. Because new and modified laws
 regulations and standards are subject to varying interpretations in many cases due to their lack of specificity












currently have no investment policies as they pertain to real estate




























Item 5.&#160; Market for Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities



 2013 our shares have been approved for trading under the symbol &#8220;TDNT&#8221;.&#160;&#160;As of the date of this filing
 there has been no active trading of our securities
 and
 therefore




 last sale prices and volume information in over-the-counter (OTC) securities.&#160; The OTCBB is not an issuer listing service
 market or exchange. Although the OTCBB does not have any listing requirements per se
 to be eligible for quotation on the OTCBB




 2016
 we had 31
000
000 Shares of $0.001 par value common stock issued and outstanding held by



000
000 shares of common stock outstanding as of November 30
 2016
 10
000
000 shares are owned by Mark Holcombe
 a former officer and current director










 we intend to retain any earnings to finance the development and expansion of our business
 and we do not anticipate paying any cash dividends on our common stock. Any future determination to pay dividends will be at the discretion of the Board of Directors and will be dependent upon then existing conditions
 including our financial condition and results of operations
 capital requirements
 contractual restrictions
 business prospects







 as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5
000
000 or individuals with net worth in excess of $1
000
000 or annual income exceeding $200
000 or $300
000 jointly with their spouses). For transactions covered by the Rule
 the broker/dealer must make a special suitability determination for the purchase and have received the purchaser's written agreement to the transaction prior to the sale. Consequently




 such as bid and offer quotes
 a dealers spread and broker/dealer compensation; the broker/dealer compensation
 the broker/dealers duties to its customers






 2016








































































Brand Director
 Chief Financial Officer











































































 Director



























































































































































































































































































































































































































































































































358




























































 2016 and includes information available to February 28
 2017









 business strategy
 budgets
 litigation
 projected costs
 capital expenditures
 financial results
 taxes
 plans and objectives.&#160; In some cases
 forward-looking statements can be identified by terms such as &#8220;anticipate&#8221;
 &#8220;estimate&#8221;
 &#8220;intend&#8221;
 &#8220;project&#8221;
 &#8220;potential&#8221;
 &#8220;continue&#8221;
 &#8220;believe&#8221;
 &#8220;expect&#8221;
 &#8220;could&#8221;
 &#8220;would&#8221;
 &#8220;should&#8221;
 &#8220;might&#8221;
 &#8220;plan&#8221;
 &#8220;will&#8221;
 &#8220;may&#8221;
 &#8220;predict&#8221;
 or other similar expressions concerning matters that are not historical facts. To the extent any forward-looking statements contain future-oriented financial information or financial outlooks
 such information is being provided to enable a reader to assess our financial condition
 material changes in our financial condition
 our results of operations
 and our liquidity and capital resources.&#160; Readers are cautioned that this information may not be appropriate for any other purpose









 results of operations
 performance
 and business prospects and opportunities.&#160; While we consider these assumptions to be reasonable
 based on information currently available
 they may prove to be incorrect.&#160; Forward-looking statements are also subject to certain factors



















 related revenues and expenses





































 measured on a first-in
 first out basis
 or estimated net realizable value.&#160; In order to determine the value of inventory at the balance sheet date
 we evaluate a number of factors to determine the adequacy of provisions for inventory.&#160; These factors include the age of inventory
 the amount of inventory held by type
 future demand for products
 and the expected future selling price we expect to realize by selling the inventory.&#160; Our estimates are judgmental in nature and are made at a point in time
 using available information
 expected business plans
 and expected market conditions.&#160; As a result

















 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include





























a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&#160;








 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets

















 rebates


































 directors and service providers.&#160; For grants of stock options
 we are required to estimate a number of inputs at each grant date
 such as the estimated life of the option
 future stock price volatility
 and the forfeiture rate used in the Black-Scholes option-pricing model to determine a fair value for the options granted to employees or non-employee directors.&#160;&#160; Once determined at the grant date

















 investment and other tax credits
 as well as the provision for income taxes at different rates in various jurisdictions.&#160; In making an estimate of our income tax liability


















Results of Operations for the Fiscal Years Ended November 30
 2016 and November 30
 2015


 and the fiscal years ended November 30












































































































681









511

































187









169








While still in the early stages of commercialization
 our revenues increased in 2016 to $168
042 versus $16

 primarily through e-retailers. Gross Profit increased accordingly in 2016 to $70
304 or 41.8% of revenues versus $6
618 or 39.9% of revenues in the prior year
&#174; products
 resulting in reduced revenues. Even so
 we expect both Everlast&#174; and Brain Armor&#174; revenues as well as sales of private label nutritional health products to continue to ramp-up into 2017 as commercial efforts gain traction
&#174; product in April of 2017
 we adjusted fourth quarter revenues down by $94
308 and the corresponding gross profit down by $45










































































293











































































































































 2016 were $2
681
358 as compared to $2
511
893 for the comparative period in 2015
 an increase of 6.7%.&#160; The increase in our operating expenses is primarily due to increased general and administrative costs as we build out our organization and roll-out our product offerings
 as well as an increase in royalty fees of $88
184 as per the terms of the Everlast License Agreement and incremental non-cash costs of $275






 2016 were $576
073 versus $664
549 in the comparative period in 2015
 a decrease of 13.3%. The decrease was due to a decrease in interest expense of $88







 2016 was $1
527
624. Management believes the current funds available to the company will be sufficient to fund our operations for the next twelve months. We are an early growth stage company and generated $168




 2016 we had a loan of $200
000 payable to a former related party (CIC) bearing interest at 8% per annum due March 4 2017. The earlier loan of $180
000 plus outstanding interest was repaid in full on September 27




000
 $100
000 and $250
000 bearing interest at the rate of 8.0%
 8.0% and 10.0% per annum respectively were all repaid during the last quarter of the year ended November 30




 2015
 we entered into a securities purchase agreement with a non-US institutional investor whereby we agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the company&#8217;s common stock.&#160; We received $1
800
000 of the funds from the transaction on February 5
 2015 and the balance of $500
000 on May 14
 2015.&#160; On September 26
 2016
 we entered into a Convertible Promissory Note Amendment Agreement with this investor whereby we agreed to extend the maturity date and amend the interest payable on the senior secured convertible debentures
 whereby we extended the term of the notes through September 30
 2019 and interest rate was increased from 6% per annum to 8% per annum.&#160;&#160; The convertible debentures are convertible into shares of the Company&#8217;s common stock at an initial conversion price of $.71 per share for an aggregate of up to 3
239




 2016
 we entered into a Securities Purchase Agreement with a non-US institutional investor&#160;&#160; pursuant to which
 in consideration for proceeds of $4
100
000
 we issued a secured convertible promissory note in the amount of $4
100
000.&#160; Pursuant to the Securities Purchase Agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at our request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds within 120 days following September 26
 2016.&#160; We intend to use the proceeds of the secured convertible note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans. In consideration of each advance made by the investor pursuant to the Securities Purchase Agreement
 we will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note will be secured in first priority against the present and after acquired assets of the Company
 and will be convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price per share of $.60
 equal to a 25% discount to the 10 day average closing price of the Company&#8217;s common stock for the period immediately preceding the issuance of the applicable note. Due to the note being convertible to the Company common shares
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1
366
667 which was recognized as debt discount. As of November 30
 2016
 $80
831 of debt discount was amortized and the unamortized discount is $1
285









































































200






























300












 2013 that was assigned to us in the assignment Agreement dated December 23







300






 changes in financial condition
 revenues or expenses
 results of operations
 liquidity




























 including our principal executive officer and the principal financial officer
 we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures
 as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934
 as of the end of the period covered by this report.&#160; Based on this evaluation











 including our principal executive and financial officer
 recorded
 processed
 summarized and reported within the time periods specified in SEC rules and forms relating to our company







 as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act
 for the Company.&#160; Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that
 in reasonable detail
 accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles
 and that our receipts and expenditures are being made only in accordance with authorizations of its management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition




 and accordingly
 even effective internal control can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect material misstatements. In addition




 or combination of significant deficiencies




 management conducted an evaluation of the effectiveness of our internal control over financial reporting
 as of the Evaluation Date
 based on the framework set forth in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).&#160; Based on its evaluation under this framework









We do not have a financial expert on our audit committee or a fully independent Board of Directors


























 2016 that have materially affected
 or are reasonably likely to materially affect












Item 10.&#160; Directors
 Executive Officers and Corporate Governance













































































































































































 Director and Chair of the Board of Directors on December 2












 was appointed&#160; President on December 2
 2016. He was appointed as a Director of our company on November 5
 2007 and served as Chief Executive Officer
 President
 Secretary and Treasurer through March 21
 2014.&#160; He also serves as 
























 was appointed Director of Operations on December 2
 2016 at which time he resigned as President and CEO and Director of the company.











 was appointed as Chair of the Audit Committee on December 2
 2016 and as a&#160; Director and Chair of the Governance Committee of our company on March 21
 2014.











 was appointed Brand Director&#160; on November 30


 2014.&#160; He resigned as President of the Company on December 15
 2015 and as Secretary on December 2
 2016.











 was appointed as a Controller of our company on March 21
 2014.




















Anthony Pallante





 Mr. Pallante served as a Senior Vice President and Officer at Cott Beverages. Prior to Cott
 he served as the President and Principle of Exclusive Beverage
 the Ontario Royal Crown Cola franchise



Mark Holcombe





 corporate development and asset management. Mr. Holcombe has over 23 years of banking and corporate finance experience. He has significant experience in M&amp;A advisory
 corporate restructurings and public and private debt and equity financings. Formerly




 he was a Senior Advisor to Providence Advisors Limited
 Managing Director and Head of Asset Management for Madison Williams Holdings
 LLC in New York City and Head of Corporate Development/Private Equity of GEM Global Equities Management S.A. Also
 He has worked as a senior investment banker at Global Hunter Securities
 Donaldson
 Lufkin and Jenrette
 Gleacher NatWest/NatWest Markets











 he applied these skills in the successful growth of The Activation Group (TAG)
 a strategic marketing and communications agency. Mr. Cluett founded TAG in 2014 and continues to serve as its president. Prior to founding TAG
 he served as a Business Director with Ogilvy
 a global advertising agency where he was responsible for a multinational business portfolio and was based out of New York City
 Toronto and Montreal. This was preceded by experience as Director of Strategy with 141 Worldwide








000 in revenue to over $50 million before the business was sold in September






Scott Chapman







 Bahamas); and in institutional
 retail sales with Midland Walwyn (Montreal



 Mr. Chapman&#8217;s responsibilities have included corporate finance
 venture capital



 Mr. Chapman has been the owner of Hyperion Management. Hyperion is in the business of venture capital
 marketing












Michael Browne
 Brand Director




 Frito-Lay
 Mars Inc.
 MillerCoors LLC. Mr. Browne has managed power brands in the categories of: ready to eat cereal
 salty snacks
 confectionery




 Mr. Browne was employed by MillerCoors in various positions.&#160; Most recently
 he was the Vice President of Marketing for the above premium portfolio from August 2008 to November 2010.&#160; As Vice President of Marketing
 Mr. Browne lead the above premium portfolio including key brands that included Blue Moon
 Leinenkugel
 Molson
 and SAB international imports (Peroni
 Pilsner Urquell
 Grolsch)
 and super premium brands (Sparks
 Miller Chill). Mr. Browne drove craft beer share growth and increases in value of key franchises.&#160;&#160; Further
 his broad range of commercial responsibilities included sales execution planning
 cultivating key distributor relationships
 collaborating with global trademark owners








 most notably in the automotive industry. Mr. Salvo has served in many capacities
 most recently as controller and finance manager with Meritor Suspension Systems Company for 14 years. He has also worked for Rockwell International for 11 years as Manager of Financial Analysis. Mr. Salvo has extensive financial management experience and served as a key member of various management teams. His experience includes development of business operating plans
 preparation of sales and profit projections
 preparation of monthly financial statements and variance analysis
 cash flow forecasts
 standard costing and inventory controls











 food and nutritional products
 marketing



 operational and business experience give them the qualifications and skills necessary to serve as directors of our company. Our board of directors consists solely of Mr. 









 none of our directors or executive officers has






















 or of any partnership
 corporation or business association of which he was a general partner or executive officer























 judgment
 or decree
 not subsequently reversed
 suspended or vacated
 of any court of competent jurisdiction or federal or state authority
 permanently or temporarily enjoining
 barring
 suspending or otherwise limiting
 his involvement in any type of business
 securities
 futures
 commodities
 investment
 banking
 savings and loan
 or insurance activities












 and the judgment has not been reversed
 suspended












 or a party to
 any federal or state judicial or administrative order
 judgment
 decree
 or finding
 not subsequently reversed
 suspended or vacated (not including any settlement of a civil proceeding among private litigants)
 relating to an alleged violation of any federal or state securities or commodities law or regulation
 any law or regulation respecting financial institutions or insurance companies including
 but not limited to
 a temporary or permanent injunction
 order of disgorgement or restitution
 civil money penalty or temporary or permanent cease-and-desist order
 or removal or prohibition order












 or a party to
 any sanction or order
 not subsequently reversed
 suspended or vacated
 of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)))
 any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)))
 or any equivalent exchange
 association










 as amended
 requires our executive officers and directors and persons who own more than 10% of a registered class of our equity securities to file with the SEC initial statements of beneficial ownership
 reports of changes in ownership and annual reports concerning their ownership of our shares of common stock and other equity securities
 on Forms 3
 4 and 5
 respectively. Executive officers



 or written representations from certain reporting persons
 we believe that during fiscal year ended November 30
 2016
 all filing requirements applicable to our officers




that applies to our officers
 directors and employees. When we do adopt a code of ethics
 we will disclose it in a Current Report on Form 8-K.




 and is &#8220;independent&#8221; as the term is used in Item 7(d)(3)(iv) of Schedule 14A under the Securities Exchange Act of 1934























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 health
 annuity
 insurance
 profit sharing or similar benefit plans; however
 we may adopt plans in the future. Except for our stock option plan
 of which no options were issued in 2016




















































































































































































































































































































































































441

















































































































341














































000





















000





















000

















































000

































 2017 of 31
000






















Certain Relationships and Related Transactions
 and Director Independence



 2016 fiscal year
 or any currently proposed transaction
of $120
000 or one percent of the average of our total assets at year end for the last two completed fiscal years
 and in which any related person had or will have a direct or indirect material interest (other than compensation described under &#8220;Executive Compensation&#8221;). We believe the terms obtained or consideration that we paid or received
 as applicable
 in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received
 as applicable













 our Director of Operations
 was a former Managing Partner and Strategic Advisor of Continental Ingredients with 47.0% ownership share in Continental Ingredients. The Managing Partners of Continental Ingredients sold the business to Quadra on September 1





 who is one of three directors of our company
 was our only promoter in the past five fiscal years. Mr. Holcombe has not received
 nor will he receive
 anything of value from us
 directly or indirectly in his capacity as promoter. However
 he holds 10
000
000 or approximately 32.26% of our issued and outstanding common shares.&#160; Additionally
 Mr. Holcombe receives fees for his service on our Board of Directors plus fees as a contracted service provider for the Company.&#160; As of February 28

































































































































 consisting of Mark Holcombe








 all of the members of the committees are not independent. We believe that our board of directors is capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The board of directors of our company does not believe that it is necessary to have a completely independent audit
 compensation or corporate governance committee at this time because we believe that the functions of such committees can be adequately performed by the existing board of directors. Additionally







450 and for other services were $Nil during the year ended November 30
 2016.&#160; 



500 and for other services were $Nil during the year ended November 30































































































































 the registrant caused this report to be signed on its behalf by the undersigned





































































































































































 the &#8220;Company&#8221;) as of November 30
 2016 and 2015
 and the related consolidated statements of operations




 nor were we engaged to perform
 an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly
 we express no such opinion. An audit includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management




 the consolidated financial statements referred to above present fairly
 in all material respects
 the financial position of Trident Brands Incorporated and subsidiaries as of November 30
 2016 and 2015 and the results of their operations and their cash flows for the years then ended





/s/ MaloneBailey
 LLP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 








































































































527













































































879































425































304










































































































 net of discount $8
812 and $0




















 net of discount $18
135 and $0



















 net of discount $0 and $147
230












152



















998


















 net of discount $1
285






114





























843







998































 $0.001 par value
 300
000














000














 2016 and 28
000
000 as of November 30
 2015

























431







177



































936









800














538









609






















304





































































































































































































681









511

























611









505

































































































187











169

























135









155




















































































696







000


























































































































































 November 30






000
























































































































































&#160; November 30


















155


















169




































 November 30






000


















177









800






















609

















































366















366












000














697















700













































































&#160; November 30


















135


















187




































 November 30






000


















431









936






















538












































































































187











169







































































































































































































480









204


























































































































100







300












820







391























339





























































527















































366





















700

























































































































































 &#8220;our&#8221;
 &#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&#160; The Company was formed to engage in the acquisition




 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation
























 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products&#160; Inc.







 &#8220;Earnings Per Share&#8221;
 specifies the computation








































 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include



























































 more likely than not







 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets





 on a periodic basis
 long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators
 such as the nature of the assets
 the future economic benefit of the assets
 any historical or future profitability measurements
 as well as other external market conditions or factors that may be present. If these impairment indicators are present or other factors exist that indicate that the carrying amount of the asset may not be recoverable





 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any







 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value









 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including quoted forward prices for commodities
 time value
 volatility factors
 and current market and contractual prices for the underlying instruments

















 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps














042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products
 we adjusted fourth quarter revenues downward by $94




 product is shipped or delivery is complete (depending on the terms)







738. Cost of sales was adjusted downward by $49







 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award







 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)














 in the opinion of management























 controls
 is controlled by




 its management












 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 through the issuance of a secured convertible promissory note. The investor has agreed to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate). On November 30
 2016 the Company had $1
527
624 in cash and has access to $5
900
000 available from the investor. The Company feels this represents substantial liquid resources (cash &amp; available financing)
 sufficient to meet the Company&#8217;s obligations for the next twelve months
 and as a result
 the going concern disclosure is not warranted for the year ended November 30







 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125
000 stock options to its president
 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5




 2015
 Michael Browne&#8217;s stock options were amended to 625




 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1




 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options will expire on December 31
 2016 unless exercised. The total outstanding stock options as of November 30
 2016 are 2
358

















703. In 2016
 the Company expensed $111
994 as compensation expense compared to $482
653 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5























































875





































































































































375












































































































































358




























666


























 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43




 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
000 secured related party promissory note. The relative fair value of the warrants is $35
250 which is recognized as debt discount. As of November 30
 2016
 $26
438 of the debt discount is amortized and the unamortized discount is $8







































































































































































































































































































































 2015
 Continental Ingredients Canada
 Inc. (&#8220;CIC&#8221;) of which the Company&#8217;s previous CEO owned a significant interest
 loaned the Company $180
000 bearing interest at the rate of 8% per annum
 payable on maturity




000 note was advanced during the year ended November 30
 2015. The full amount of the loan and accrued interest of $13
177 was repaid on September 27




 2016
 the Company entered into a Securities Purchase Agreement with CIC whereby the Company received proceeds of $200
000 on March 4
 2016 in return for a $200
000 secured promissory note due 12 months from the issuance date
 bearing interest at the rate of 10% per annum
 plus 100
000 warrants to purchase common shares of the Company at an exercise price of $1.35 per share for three years from the date of issue. As of November 30
 2016




 the company purchased inventory from Continental Ingredients Canada
 Inc. The total amount of inventory purchased in 2016 was $316
086 compared to $291











 one for $200
000
 one for $100
000 and the other for $250
000 bearing interest at the rate of 8.0%
 8.0% and 10.0% per annum respectively
 payable on maturity
 calculated on the principle amount of the loan outstanding. The loans for $200
000 and $250
000 were repaid on September 29
 2016 and the loan for $100
000 was repaid on October 4







 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures




800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14




 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30




 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2016

















 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities&#160; purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26




 without limitation




 the Company will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance






 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1
366
667 which was recognized as debt discount. As of November 30
 2016
 $80
831 of debt discount was amortized and the unamortized discount is $1
285










 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30




 the net value of the license was $2
425
000 after amortizing $275







 2013
 the Company entered into a Deed of Assignment Agreement with Everlast World&#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights




 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary




 or arising from its termination

















 as per the terms of the agreement
&#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%















































313









825

































859



















859








































 2016












 2017
 Trident Brands Incorporated entered into a Letter of Intent (the &#8220;LOI&#8221;) with The Activation Group
 Inc.
 an integrated marketing and advertising agency incorporated in Ontario
 Canada.&#160; Pursuant to the LOI
 Trident will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200
000 cash
 and $800
000 payable in common shares of Trident.&#160; The cash consideration is inclusive of a $50
000 deposit paid to The Activation Group upon execution of the LOI
 and $150
000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200
000 installments
 subject to the achievement of earnings targets.&#160; The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence by the Company




 on February 15
 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated


















    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing











 Anthony Pallante






















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made













 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for

























 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to me by others within those entities













 or caused such internal control over financial reporting to be designed under our supervision


























 or is reasonably likely to materially affect













 based on our most recent evaluation of internal control over financial reporting













 process













 whether or not material


























































    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing












 Michael Browne






















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made













 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for

























 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to me by others within those entities













 or caused such internal control over financial reporting to be designed under our supervision


























 or is reasonably likely to materially affect













 based on our most recent evaluation of internal control over financial reporting













 process













 whether or not material




























































    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing












 2016
 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;)
 Anthony Pallante
 as Chief Executive Officer and Director of the Company
 hereby certifies
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002




























 in all material respects


















































 except to the extent required by the Sarbanes-Oxley Act of 2002
 be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934



















    Document created using EDGARfilings PROfile 4.2.1.0
    Copyright 1995 - 2017 Summit Financial Printing















 2016
 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;)
 Michael Browne
 as Chief Financial Officer of the Company
 hereby certifies
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002




























 in all material respects























































 except to the extent required by the Sarbanes-Oxley Act of 2002
 be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934






















 February 28















2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05













2014-05-01


2014-05-05









2013-12-01


2014-11-30













2015-01-29













2015-01-01


2015-01-29













2015-02-01


2015-02-05













2015-05-01


2015-05-14









2014-12-01


2015-11-30












2014-12-01


2015-11-30












2014-12-01


2015-11-30












2014-12-01


2015-11-30














2014-12-01


2015-11-30












2014-12-01


2015-11-30









2015-11-30











2015-11-30














2016-01-06














2016-01-01


2016-01-06












2016-01-29












2016-01-01


2016-01-29













2016-02-01


2016-02-29













2016-03-04












2016-03-04













2016-03-01


2016-03-04












2016-03-01


2016-03-04












2016-03-01


2016-03-04















2016-05-01















2016-05-01














2016-04-02


2016-05-01















2016-04-02


2016-05-01















2016-04-02


2016-05-01









2016-05-31















2016-06-01















2016-06-01














2016-05-02


2016-06-01















2016-05-02


2016-06-01















2016-05-02


2016-06-01













2016-09-26













2016-09-26













2016-09-01


2016-09-26













2016-09-01


2016-09-26












2016-09-01


2016-09-29












2016-09-01


2016-09-29












2016-10-01


2016-10-04









2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30













2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30












2015-12-01


2016-11-30













2015-12-01


2016-11-30









2016-11-30











2016-11-30












2016-11-30













2017-02-01


2017-02-15














2017-02-01


2017-02-15














2017-02-01


2017-02-15









2017-02-28









2014-11-30












2014-11-30












2015-11-30












2014-11-30












2015-11-30












2014-11-30












2015-11-30












2014-11-30












2015-11-30












2016-11-30












2016-11-30












2016-11-30












2016-11-30







































































































































































&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Trident Brands Incorporated (f/k/a Sandfield Ventures Corp.) (&amp;#8220;we&amp;#8221;
 &amp;#8220;our&amp;#8221;
 &amp;#8220;the Company&amp;#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&amp;#160; The Company was formed to engage in the acquisition
 exploration and development of natural resource properties.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company is now focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement
 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 2.&amp;#160;&amp;#160; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Basis of Accounting&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company&amp;#8217;s financial statements are prepared using the accrual method of accounting.&amp;#160; The Company has elected a November 30
 year-end.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Use of Estimates and Assumptions&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The preparation of financial statements in conformity with generally accepted accounting principles&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In accordance with ASC No. 250 all adjustments are normal and recurring.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Principal of Consolidation&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company consolidated financial statements as of November 30
 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products&amp;#160; Inc.
&amp;#160; Brain Armor Inc. and Trident Brands International Ltd.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color:
 #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Basic Earnings (loss) Per Share&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;ASC No. 260
 &amp;#8220;Earnings Per Share&amp;#8221;
 specifies the computation
 presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.&amp;#160;&amp;#160; The Company has adopted the provisions of ASC No. 260.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding.&amp;#160; Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Cash Equivalents&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary. Management has determined that a reserve for uncollectible amounts was not required in the periods presented.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Inventory&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align:
 justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Inventories are stated at the lower of cost or market. Cost is principally determined using the first-in
 first-out (FIFO) method.&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Long-Lived Assets&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;We review our long-lived assets
 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include
 but are not limited to:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant decrease in the market price of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the extent or manner in which the asset is being used;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the business climate that could affect the value of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current period loss combined with projection of continuing loss associated with use of the asset; and&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div
 style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist
 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets
 we may incur charges for impairment in the future.&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company evaluates
 on a periodic basis
 long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators
 such as the nature of the assets
 the future economic benefit of the assets
 any historical or future profitability measurements
 as well as other external market conditions or factors that may be present. If these impairment indicators are present or other factors exist that&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;indicate that the carrying amount of the asset may not be recoverable
 then an estimate of the undiscounted value of expected future operating cash flows is used to determine whether the asset is recoverable and the amount of any impairment is measured as the difference between the carrying amount of the asset and its estimated fair value. The fair value is estimated using valuation techniques such as market prices for similar assets or discounted future operating cash flows.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&amp;#160;&lt;/font&gt;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;&lt;u&gt;Beneficial Conversion Features&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The intrinsic value of a beneficial conversion feature inherent to a convertible note payable
 which is not bifurcated and
 accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any
 to the fair value of the common shares at the commitment date to be received upon conversion.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820
 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value
 and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 1&amp;#160; &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives
 marketable securities and listed equities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 2&amp;#160; - Pricing inputs are other than quoted prices in active markets included in level 1
 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including quoted forward prices for commodities
 time value
 volatility factors
 and current market and contractual prices for the underlying instruments
 as well as other relevant economic measures.&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps
 options and collars.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space:
 normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 3&amp;#160;&amp;#160; &amp;#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&amp;#8217;s best estimate of fair value.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Revenue&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast&amp;#174; and Brain Armor&amp;#174; brands
 and functional food ingredients under the Oceans Omega brand.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Revenue for 2016 was $168
042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products
 we adjusted fourth quarter revenues downward by $94
308 based on a calculation of the estimated product to be returned by one of our customers in the second quarter of 2017.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company records revenue based on the following four criteria: collection probability is reasonably assured
 product is shipped or delivery is complete (depending on the terms)
 persuasive evidence of an arrangement with the customer exists and the price to the customer can be determined.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Cost of Sales&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Cost of sales includes the direct purchase cost of the product based on the FIFO method. Cost of sales for 2016 was $97
738. Cost of sales was adjusted downward by $49
040 in the fourth quarter for the estimated product to be returned as noted above under Revenue.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows:
 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Employee Stock-Based Compensation&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The company accounts for employee stock-based compensation in accordance with ASC-718
 &amp;#8220;Compensation-Stock Compensation&amp;#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award
 usually the vesting period.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Non-Employee Stock-Based Compensation:&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50
 &amp;#8220;Equity Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;)
 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Income taxes are provided in accordance with ASC No. 740
 Accounting for Income Taxes.&amp;#160; A deferred tax asset or liability is recorded for all temporary differences between financial and tax&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;reporting and net operating loss carryforwards.&amp;#160; Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal;
 -webkit-text-stroke-width: 0px;&gt;Deferred tax assets are reduced by a valuation allowance when
 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&amp;#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Related Parties&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries
 controls
 is controlled by
 or is under common control with the Company.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Related parties also include principal owners of the Company
 its management
 members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company has evaluated all the recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company&amp;#8217;s financial statements&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 4.&amp;#160;&amp;#160; WARRANTS AND OPTIONS&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On May 5
 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&amp;#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125
000 stock options to its president
 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5
 2019.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On November 30
 2015
 Michael Browne&amp;#8217;s stock options were amended to 625
000.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On May 1
 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&amp;#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1
 2016 remain in place.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On September 30
 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options will expire on December 31
 2016 unless exercised. The total outstanding stock options as of November 30
 2016 are 2
358
333.&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company used the Black-Scholes model to value the stock options at $646
703. In 2016
 the Company expensed $111
993 as compensation expense compared to $482
653 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5
 4.0.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new
 roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The following table represents stock option activity as of and for the periods ended November 30
 2016 and 2015:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 800px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Options&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Weighted Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; width: 192px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
875
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;4.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px;
 vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;250
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;.89&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;750
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
375
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.15&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;983
334&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.4&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px;
 vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;300
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.73&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5.0&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;316
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff;
 width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
358
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.51&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
666
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.17&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$57
500&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On January 29
 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43
526 of the debt discount is amortized and the unamortized discount is $0.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On March 4
 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
000 secured related party promissory note. The relative fair value of the warrants is $35
250 which is recognized as debt discount. As of November 30
 2016
 $26
438 of the debt discount is amortized and the unamortized discount is
 $8
812.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The exercise price of both warrants is $1.35 with a term of 3 years and these are vested immediately. The Company uses the Black-Scholes model to value the warrants. Following are the assumptions used: Discount rate .9%; Volatility 76.25% and 77.30% respectively.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The following table represents warrant activity for the periods ended November 30
 2016 and 2015:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 800px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Warrants&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Weighted&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Contractual Life&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; width: 192px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff;
 vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align:
 top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.21&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom;
 valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 5.&amp;#160;&amp;#160; RELATED PARTY TRANSACTIONS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company neither owns nor leases any real or personal property. The Company is paying a director $750 per month rent for use of office space and services.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;During the quarter ended November 30
 2015
 Continental Ingredients Canada
 Inc. (&amp;#8220;CIC&amp;#8221;) of which the Company&amp;#8217;s previous CEO owned a significant interest
 loaned the Company $180
000 bearing interest at the rate of 8% per annum
 payable on maturity
 calculated on the principal amount of the&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;loan outstanding. The $180
000 note was advanced during the year ended November 30
 2015. The full amount of the loan and accrued interest of $13
177 was repaid on September 27
 2016.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On February 29
 2016
 the Company entered into a Securities Purchase Agreement with CIC whereby the Company received proceeds of $200
000 on March 4
 2016 in return for a $200
000 secured promissory note due 12 months from the issuance date
 bearing interest at the rate of 10% per annum
 plus 100
000 warrants to purchase common shares of the Company at an exercise price of $1.35 per share for three years from the date of issue. As of November 30
 2016
 the full amount of the loan is outstanding. See note 4 for valuation of warrants.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;During the year
 the company purchased inventory from Continental Ingredients Canada
 Inc. The total amount of inventory purchased in 2016 was $316
086 compared to $291
385 the previous year.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On September 1
 2016 CIC was sold to an unrelated third party and as a result the Company&amp;#8217;s previous CEO no longer owns a significant interest.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 6.&amp;#160; LOAN PAYABLE &amp;#8211; THIRD PARTY&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;During 2016 the Company had three short term loans
 one for $200
000
 one for $100
000 and the other for $250
000 bearing interest at the rate of 8.0%
 8.0% and 10.0% per annum respectively
 payable on maturity
 calculated on the principle amount of the loan outstanding. The loans for $200
000 and $250
000 were repaid on September 29
 2016 and the loan for $100
000 was repaid on October 4
 2016.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 7.&amp;#160; CONVERTIBLE NOTE&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On January 29
 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the company&amp;#8217;s common stock.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company received $1
800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14
 2015.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The convertible debentures are convertible into shares of the Company&amp;#8217;s common stock at an initial conversion price of $.71 per share
 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30
 2019.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Due to the note being convertible to common shares of the Company
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2016
 the full amount of the debt discount has been amortized.&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On September 26
 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities&amp;#160; purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&amp;#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26
 2016.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif;
 white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company intends to use the proceeds of the secured convertible note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;In consideration of each advance made by the investor pursuant to the securities purchase agreement
 the Company will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note will&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;be secured in first priority against the present and after acquired assets of the Company
 and will be convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $.60 per share.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Due to the note being convertible to common shares of the Company
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1
366
667 which was recognized as debt discount. As of November 30
 2016
 $80
831 of debt discount was amortized and the unamortized discount is $1
285
836.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company analyzed the embedded conversion option for derivative accounting consideration under ASC 815-15 &amp;#8220;Derivatives and Hedging&amp;#8221; and determined that the conversion option should be classified as equity.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 9.&amp;#160; EVERLAST LICENCE AGREEMENT&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On December 23
 2013
 the Company entered into a Deed of Assignment Agreement with Everlast World&amp;#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;title
 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary
 Sports Nutrition Products Inc.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Everlast Licence Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the Licence Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the Licence Agreement
 or arising from its termination
 Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the Licence Agreement as if it were the Licensee.&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Royalty Calculation
 as per the terms of the agreement
&amp;#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&amp;#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&amp;#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&amp;#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%
 whichever is greater.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 10.&amp;#160; INCOME TAXES&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Deferred tax assets:&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; margin-left: 10pt; font-size: 10pt;&gt;Net operating tax carryforwards&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5
313
340&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
825
245&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; margin-left: 10pt; font-size: 10pt;&gt;Tax Rate&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Gross deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left;
 background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;988
836&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Valuation allowance&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(988
836&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 1324px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;As of November 30
 2016
 the Company has a net operating loss carryforward of approximately $5.3&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;million. Net operating loss carryforwards expires twenty years from the date the loss was incurred.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carryforwards are expected to be available to reduce taxable income.&amp;#160; As the achievement of required future taxable income is uncertain
 the Company has recorded a
 valuation allowance.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 11.&amp;#160; SUBSEQUENT EVENTS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On February 15
 2017
 Trident Brands Incorporated entered into a Letter of Intent (the &amp;#8220;LOI&amp;#8221;) with The Activation Group
 Inc.
 an integrated marketing and advertising agency incorporated in Ontario
 Canada.&amp;#160; Pursuant to the LOI
 Trident will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200
000 cash
 and $800
000 payable in common shares of Trident.&amp;#160; The cash consideration is inclusive of a $50
000 deposit paid to The Activation Group upon execution of the LOI
 and $150
000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200
000 installments
 subject to the achievement of earnings targets.&amp;#160; The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence by the Company
 and to the negotiation and completion of a definitive agreement among the parties and the shareholders of The Activation Group.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Also
 on February 15
 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated
 with responsibility for business strategy execution and commercialization.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Basis of Accounting&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company&amp;#8217;s financial statements are prepared using the accrual method of accounting.&amp;#160; The Company has elected a November 30
 year-end.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Principal of Consolidation&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company consolidated financial statements as of November 30
 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products&amp;#160; Inc.
&amp;#160; Brain Armor Inc. and Trident Brands International Ltd.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Basic Earnings (loss) Per Share&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;ASC No. 260
 &amp;#8220;Earnings Per Share&amp;#8221;
 specifies the computation
 presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.&amp;#160;&amp;#160; The Company has adopted the provisions of ASC No. 260.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding.&amp;#160; Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Cash Equivalents&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Inventory&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Inventories are stated at the lower of cost or market. Cost is principally determined using the first-in
 first-out (FIFO) method.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;&lt;u&gt;Beneficial Conversion Features&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The intrinsic value of a beneficial conversion feature inherent to a convertible note payable
 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any
 to the fair value of the common shares at the commitment date to be received upon conversion.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Employee Stock-Based Compensation&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The company accounts for employee stock-based compensation in accordance with ASC-718
 &amp;#8220;Compensation-Stock Compensation&amp;#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award
 usually the vesting period.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Non-Employee Stock-Based Compensation:&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50
 &amp;#8220;Equity Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;)
 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820
 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value
 and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 1&amp;#160; &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives
 marketable securities and listed equities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 2&amp;#160; - Pricing inputs are other than quoted prices in active markets included in level 1
 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including quoted forward prices for commodities
 time value
 volatility factors
 and current market and contractual prices for the underlying instruments
 as well as other relevant economic measures.&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps
 options and collars.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 13.5pt; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Level 3&amp;#160;&amp;#160; &amp;#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&amp;#8217;s best estimate of fair value.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Use of Estimates and Assumptions&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In accordance with ASC No. 250 all adjustments are normal and recurring.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Income taxes are provided in accordance with ASC No. 740
 Accounting for Income Taxes.&amp;#160; A deferred tax asset or liability is recorded for all temporary differences between financial and tax&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;reporting and net operating loss carryforwards.&amp;#160; Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Deferred tax assets are reduced by a valuation allowance when
 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&amp;#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Revenue&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast&amp;#174; and Brain Armor&amp;#174; brands
 and functional food ingredients under the Oceans Omega brand.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Revenue for 2016 was $168
042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products
 we adjusted fourth quarter revenues downward by $94
308 based on a calculation of the estimated product to be returned by one of our customers in the second quarter of 2017.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company records revenue based on the following four criteria: collection probability is reasonably assured
 product is shipped or delivery is complete (depending on the terms)
 persuasive evidence of an arrangement with the customer exists and the price to the customer can be determined.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Related Parties&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries
 controls
 is controlled by
 or is under common control with the Company.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Related parties also include principal owners of the Company
 its management
 members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company has evaluated all the recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company&amp;#8217;s financial statements&lt;/div&gt;


&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 800px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Options&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Weighted Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; width: 192px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
875
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;4.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align:
 left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;250
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;.89&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;750
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color:
 #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
375
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.15&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;983
334&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.4&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;300
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.73&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom;
 valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5.0&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;316
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
358
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom
 nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.51&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
666
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.17&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$57
500&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;


&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Deferred tax assets:&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; margin-left: 10pt; font-size: 10pt;&gt;Net operating tax carryforwards&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5
313
340&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
825
245&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; margin-left: 10pt; font-size: 10pt;&gt;Tax Rate&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Gross deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div
 style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;988
836&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1324px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Valuation allowance&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(988
836&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 1324px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 157px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 17px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 156px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 16px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;











































































































 as per the terms of the agreement
 are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the previous Year's Annual Minimum Guaranteed Royalty plus 10%





























































000 installments


























&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 3.&amp;#160;&amp;#160; LIQUIDITY&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On September 26
 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 through the issuance of a secured convertible promissory note. The investor has agreed to make additional investments at the Company&amp;#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate). On November 30
 2016 the Company had $1
527
624 in cash and has access to $5
900
000 available from the investor. The Company feels this represents substantial liquid resources (cash &amp;amp; available financing)
 sufficient to meet the Company&amp;#8217;s obligations for the next twelve months
 and as a result
 the going concern disclosure is not warranted for the year ended November 30
 2016.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;NOTE 8.&amp;#160; INTANGIBLE ASSETS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;On January 22
 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&amp;#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;2016
 the net value of the license was $2
425
000 after amortizing $275
000.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary. Management has determined that a reserve for uncollectible amounts was not required in the periods presented.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;The Company evaluates
 on a periodic basis
 long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators
 such as the nature of the assets
 the future economic benefit of the assets
 any historical or future profitability measurements
 as well as other external market conditions or factors that may be present. If these impairment indicators are present or other factors exist that&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;indicate that the carrying amount of the asset may not be recoverable
 then an estimate of the undiscounted value of expected future operating cash flows is used to determine whether the asset is recoverable and the amount of any impairment is measured as the difference between the carrying amount of the asset and its estimated fair value. The fair value is estimated using valuation techniques such as market prices for similar assets or discounted future operating cash flows.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Long-Lived Assets&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;We review our long-lived assets
 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include
 but are not limited to:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant decrease in the market price of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the extent or manner in which the asset is being used;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the business climate that could affect the value of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current period loss combined with projection of continuing loss associated with use of the asset; and&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify;
 widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist
 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets
 we may incur charges for impairment in the future.&lt;/div&gt;


&lt;div style=text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&lt;u&gt;Cost of Sales&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;&gt;Cost of sales includes the direct purchase cost of the product based on the FIFO method. Cost of sales for 2016 was $97
738. Cost of sales was adjusted downward by $49
040 in the fourth quarter for the estimated product to be returned as noted above under Revenue.&lt;/div&gt;


&lt;table style=widows: 2; text-transform: none; text-indent: 0px; width: 95%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 800px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Warrants&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Weighted&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Contractual Life&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; width: 192px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2014&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top;
 valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align:
 bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom;
 valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 190px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 191px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 800px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 188px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 190px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 191px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.21&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 20px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 192px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;







	
	
	
	


	


	

	

	
	
	

	







	












 February 28






























































































































































































































































































































 February 28
































































 February 28
























































































































































































































































































































































































































































































































 February 28




































































 at Carrying Value







 Net


















































 Related Parties



 net of discount $8
812 and $0






 net of discount $18
135 and $0






 net of discount $0 and $147
230











 net of discount $1
285












 Value


 $0.001 par value
 300
000
000 shares authorized; 31
000
000 shares issued and outstanding as of November 30
 2016 and 28
000
000 as of November 30
 2015






































 Unamortized Discount





 Unamortized Discount

















 Shares






 Shares




















































































































 Value





 Shares





 Value
 Share-based Compensation
























 but not limited to
 legal
 accounting
 broker




























































































 Convertible








































































































































 Trade and Other Accounts Receivable
 Allowance for Doubtful Accounts










 Finite-Lived






















































 Stock Options























 Goods




















































































 Options





 Options
 Outstanding







 Options
 Exercisable







 Options
 Grants in Period






 Options





 Options





 Options
 Outstanding





 Options
 Outstanding






 Options
 Exercisable






 Options
 Grants in Period






 Options
 Outstanding







 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months




 Options
 Exercisable





 Options
 Exercisable

















































































































































































Value of options outstanding































 Fair Value Assumptions










 Fair Value Assumptions





 Fair Value Assumptions





 Unamortized Discount (Premium)








































 Interest Rate





















 Purchased Goods







































































 Converted Instrument




























 Convertible














































































































































































































 Consideration Transferred










 Options
 Nonvested Options Forfeited






















Stock payments payable in four installments


















 February 28


















































































































































































































































































































































































































































































































































































































































































































































































































































































































begin 644 pg7.jpg

# P
!PD.#PT
#@L
# S_

# P
# P
# P
# P
# P
# P
# P
# P
M# P
# P
# P
# P
# P
# P
# P
# S_P  1 _ E@# 2(  A$! Q$!_\0

M! 0   %] 0(#  01!1(A
4$&$U%A!R)Q%#*!D:$((T*QP152T? D
V)R@@D*


7&



B



G*TM/4

!  (1 Q$ /P#]_**** B
MBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH ***

MIZC4WB13-'&=F6E565RN



_N7^8:GKG_  G&B_\ 07TO
M_P H_\ &C_A.-%_Z^E_P#@5'_C7DO_  [4_9X_Z(=\)_\ PE;+_P-T?\
M#M3]GC_HAWPG_P#5LO_ (W1:C_


)6R_\ C='_  [4_9X_



E



F?<]A7

ML3DX -?D%^PI^R1\9OV+?VR8=2\3^ OC;H.@Z]I^BSQZ5X&\*:/X@TBUB;5-


M#6#X9_X*;_LZ^-/'B'7](^.7PIU+1/4


M#Q%\&;[XBV'Q=^&][X#TN[6PO?$$'B*TDTZTN6956&28/L20ETPC$$[UXY%=





MX\TS3)K[PKJ+ZKY_]DZ/K%L$GU'3)

MWX5_]./B&O=:\*\!_P#*2;XG_P#9._O_IQ\0U[K6U?XEZ+\D)!1116(PHHH
MH **** BBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH **** BBB@
M HHHH **** BBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH **** 
MBBB@ HHHH **** BBB@#QS_ (*)_P#*/SXZ?]D]U_\ ]-MQ7I_@C_D2](_Z

[U15-W-SM9=BQ_N]N'?

:^ /\
M@N=\8/$OPK\9_!6/P]XBUG0EU+3_ !X]U'87TEM]K^S^$=0FB+A-WERJCJ3


RF6)8=U
)_!_@+P+K'CKXN?#C1?B?X_T[PC:
M6GQ*U+2+CQ1H]AX=L;U((]9@


^&?$%EXX3Q]=Z-I_A6YN-7OW:YNK- W]J2QV\:
MV


MQTW2




_#RX\%V_AJR\3?



O'TO3(;-KMLDYD


M=:VK_$O1?DA(****Q&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !


M_P#*2;XG_P#9._O_IQ\0U[K7A7@/_E)-\3_ /LG?A7_ -./B&O=:VK_ !+T
M7Y(2BBBL1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &/\0? 6D?%3P%K?AC7[)-2T'Q'
MI\^EZE:.S*MU;3QM%+&2I# 
C


MM * 

M^'??PN_Z!WBK_P +/6O_ )+KT;XF?&#PG\%] _M7QAXFT#PMIN2/M6K:A%9P


IQ_R






/V
/'7P2^*\/P\\9^/IO$'B[*MHEUXQU35X=-\:Q ,6
M2PO[*]A:VNT59+2XM[F10=Z23)ROM%[\*=(^%NHQP_$/X$_%2'3V95;7?!?
MCK6?%.GQ C)

MR02

&&&4@AT/(((-4/AI^S#X=^#&BW-CX4O_&&
ME0SKMC%QXGU#5H[( 8 @BOIIXHE'950+P.*XY8B5M)R3[?\ !O\ H:VUV.;_
M .'??PN_Z!WBK_PL]:_^2Z/^'??PN_Z!WBK_ 
+/6O\ Y+JOIWPN^.?PTUN6

'+96*G7O#('BS1FPH)?%JHOT3)^])9H!@DD#FJYJ[^I?YO\ )V?W

M3\(_VJOAQ\=[Q[3PEXT\/:UJ

MO%VE)I^K+7*]C@/@Y^S!X*^ FN:KJ?AC3+RUU'6X(+6]NKO5;S4)IHH&E:*/

M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%



/BYXXUA25\JU\



MU!BK^5XHU;_B4QL 5^32[58; 9&/O0

M&G4X)+W&;#P#I


MOCU_5; '^V_LQ&#!8N1LMY'R0;@[GC&?+4.5D0BDW9NP


 FY&F:-2HD[OX!_
MLZ^'?V=O#U[:Z









MAEKB+MCU/P)JL_AZ4?



M





M





]2T2U\0:O:Z1)XCO%T[3FNB8XKJ
MY892$2$;!(V




M8RL/[F*QM-.=RYW117!O#(Y54E^U_\ @GA^T(/VH_V/O'C+S-6N)KY+BTN


M9SSC= TB'!VLW6O9;:YCO+=)H726*50Z.C;E=3R.*RG3G#XU8I23V8^B
TC_HG_QI_P#!U+_ .-4?\-O

MN_;ZL_#F@3W=E\)OCUK]S$



KP7Z?\ !_ ^E_BQ^VC\+?@I=_8]?\:Z*FKM_J]'L9#J

M.?&#VUC??OX=^&8GQ]LA%YXFU6]3=U5)$LH+9BI[_: I&?F!Q5'4_V ]^)

M\:?_  @=2_\ C5'_  V]I'_1/_C3_P$#J7_ ,:II8B*M+7HM?OW_$7(OM.


7$TJ6\MPY*@@*HCAD))/8#J
M:R]G-2Y6M0NMSN:*\?\ ^&N_^J8?%_\ \)O_ .V4?\-=_P#5,/B__P$W_\
M;*T^K5OY7]P71[!17C__  UW_P!4P^+_ /X3?_VRC_AKO_JF'Q?_ /;_P#M
ME'U:M_*_NZ/8**\?_X:[_ZIA\7_ /PF_P#[91_PUW_U3#XO_P#A-_\ VRCZ


=!M&%YJ-[
8?#F@7A 
=M

MNTT6-M:F!.#9:?$7;[.[*3NNY/FC'$2%R)8^[^%7QD\.?!#P!IWA?PG\&/BE
MH6@Z3&8[:SMO#.%7)+
[$R%GD=BS.[$N[
S
2Q)._P!3G3BIR5V^F_W_ .6_


M .V5E*A7D^:47]Q:LMCVBO'_P#AKO\ ZIA\7_\ PF__ +91_P -=_\ 5,/B
M_P#^$W_]LJ?JU;^5_

M-%+

M!Z5


MQ:;GI?@;QSH_Q

M$?P%^)$OBSX/_SXHG2?$&HBZ\5^![CP^MO8ZD[E5DO[0RA+.]Q\SJ?W-R1
M\_ER$SU[O_PUY_U3#XO_ /A-_P#VRE/!U$N:NOQ7JOZ0HSOHSVBO'_ /AK


MS7-';U2_

M([$5XMJ'_!.SP'HVMG5? -[XL^$6I&3SC_PA6KOIVGR28(W2::P?3Y#SD[[8

M.)F/]VN:_P&U8O^B6?&K_PDI?\ XJC_ (;5B_Z)9\:O_2E_P#BJ;I5)--Q





%G'9I^C_1Z_.U
MAK%TGU_KUV/HBO%7_;3A1R!\+OC2P!P/4N#_X]2?\-JQ?]$L^-7_A)2__
M !5+ZK4?;[U_F5]9H_S+[SVNBO%/^&U8O^B6?&K_ 
)*7_XJC_AM6+_HEGQJ


MY9*S1LFFKHX_]O'_ )
.
MSY\TJ2ID0'DDXR!V [YY]NCO^D:+
;.T-S);0L8+9'5#
P'RH&8@#)P
DXY



'36[602JV!M=6 (J2S] J*^$?&/_!;1
M_!FA?V1=_!3Q99?%NS\7Z;X0U+P-J&OZ7:R6CZC87=_97BZ@939O;30V4X5O
M



EB%


J@^_\




MW\+_ !_X-O/@A!HGCWXE2?#JUU/4?!VLO!K\!O+B&#6[2$ZC#+;P.D!'V:8N


MWD3O
W]G10B4*=[E57@  ^_**_);7_^RGQ]^'?P?\ @#XF\8:_\_#]I\:
M+[Q*+W4X?AYX@U2#P[:Z0C8)M;;4WGF:1XV+.,*BL0 K-7;^/^K?Q^^
7

M3R;S)\H4 _3*BOS.\2_\%4OC]\/?C!X ^&FH6WP?UCQ;\4/!?AK6=)U&VT34
M;'3]
O\ 6=9FM=T\37TKRP6]I$SF-9(WEE7 D0
 *'Q]_PV_Q+_8T^
-IX




H^4_



MC;2\95]@*\OCCMV/P.^/?Q'\
_MA+\
/$_B'1?B'97=@U[+J=A:Q6SZ1MB9P



M/B&.[\SX

M/!#6OPWO-)A^)VM^ X=+;PSJ^G7-M965I-/'J!UF:Y;3[F?
6TV
2+/)GY M



,JRSJT8+K&RMEUVCB1PU2_@1]9?E$QC_'EZ+\Y'
MU-3995@B9W8(B LS,<!0.I)KXS_X)3_\%7=)_;?\+0^&/%$MCI/Q/TVW#2PH
MP2#Q!&JY:YME[-P2\0SM'S E<[?3O^@7Q\F^%?PVAT32KM;?6O$99&95#/#
M:CB0\_=W9 D'C?C!&1S[FYZ5\$OCUH7Q[TS5[K0Y&==%U*739PQ!RRX9'&



M6$*:)=6^HV[.//-A/%]NM;I78(&\HM\WF4 ?LW17PQ_P3:_9:@^#OQP_:=U#




MB:9HNI:OI^BMH

RO._$'B/
M]LC6_#OB.[\/V_Q2\/\ BSX'_[5?#6N^%=2:XO+?Q5:)J]U&B0WD8

MES64T5Y;$RRRVCK\PD92 ?O#17XK^&;GXC-\:;^TT6'X^CX_7GBCX?Q^&;QC
MX@&@6.A?V%H)UF6]#G^RVB&-1$JSJTOFMP-X!'JG_!+^]\:^$O\ @J#XKA$7
MQ@\7:-XS_P$BN_$5SXWM==T^\^'\T-\GV6RD9[AM&U&4 _9Y+6'SDB/WUC



MWW

_[XC_!B]^GQ8U3Q+X%U


O%_Q
?#+Q9X0\1GX;ZJLOA^PM](T636



MNO%/PWO/AG\1-5M-&AC?Q0D]S'-]O1EE#+=B$W
1+L^]9ES_ *M-O;7G_! #

M&^YL^:? G[$_ASX4?#S]B^Z\9_LX:SJ'AC3/$'CVY\?Z7:?B[UB79(MY#8

.M:K^U;\*_$MGXU\'Q^!OA-J.C7^@RR^%-OC/2K;3K-+8

^)?C-X/T?XB^
-&
MO7OO GAN=R)KN]4 &1\$8M5.PR%PR\* K

MQO9F:3)*


1O.%56E_9N@ K\^OVR+O]D1_

ME /N#'ZU\
^.?^5?_  TM_P %'OBOXY^(ESXMM_AIJMEX-ETO2-,U];;2
M_%EUI;WLTB:E;)F26.9K5T5RBDLV-V#@ P? /[6O[$=W^SKXG_9[D\57*^
M=0A\52W\/B72-7L;/4D2[O+W6C;W]S;QQ3M!






M-8D2181YC_8SA

M$WCF2T^&E_J'QO]UB/5=/L?#=SJ]G-//K$&F74


M/]HBLREQ%]S[J.55BRUYA^PQ^P]\:_AW^RS^T;X1USP[K?A/PWXR\'1Z'X$\





M


;Z3C)=-





M_P!GJSC-6M+W7))1Y&M8VLUJ]-]K'UV)\7\VQ3Y
72ISI-2YJ=I*$FY^T4K*

M2993*H.77&P@$\X&



M@GAYX:G5G&





M_P!%TNWGG

WF-@)8I;9HF\W:R+!(=R
U=)XZ_8V^(?@+]I+QAXBETO7O%
M5GJ:/'?:O96A_TV[?RKB]O8H0991%OAFA$40=XUN(D^:-6J3X9_L-?%_7_%
MOCJU^VW^D:/XF\IHS37]G#;GQ!#]NN5FLI966:6U:6!W5)RCR11R0.T64^S

M.@W

MW1+C:K[BDJVMQ'*I'$;R*VUF0U^D'Y$:.O:3_P $^?B3X=^%_@Z7Q3XA?1F\
M$Z'X

M?:/XE\1^$M/\&ZC=0WC?Z39V


?B+5=1U[2-5NO[=FTVYU&U74Y4MKZ:PTV\TN&61!P

'AC6XT

M?LX?]E/_ /==UVMJ'Q/T?Y
3$_;[_P11^&G_94/W_IRBKW=E#J00
$$=
/<SBYM";.<LQ)\UHU9'&3EXF88#*H^ _\
M@L#_ ,$QOC9\+/$]KKT0N/B)X1M-*AFO[C0]/<#2+F.V4W4DUN&=Q%\CR;[




EX-/FOKO3VLX93_:FU+:8!
M\R(A+-P4
X']IG_@N_\ %G]G?Q+X6TX:U^S]J_\ :7PRB\?0S#0/$
0\;W4V


4/?63:C$2%VC;/&WEL(Y#7T7XO\











M&;C\3BNCIIM:+J)I.S?0*KZKJ*Z1I=S=O'/*EK$TS1P1-+*X4$D(B@LS''
MR3P*L44AGRU^T3^U=XJUCQQ\

M@MFUG

MCAX=CTCQKX5\-^+])AN$NX[+6]



MSUK3FA2XCVNJNIZAAD&G45Q%!1110 5\\_MB:C\7O%/[.?[0NCZ!X7&DS6_@

GBSXH?

HN+)ENH=1(C



MBB@ HHHH *^4_P!K#QO\7+;P5X(\1WOA;5?#=OX3^+5A-JMMX
U6\\07.I^&





'P)\
^$OB!X^\%7


M_MFJ-J
46FV^RVU F&*%91+-RQ@,DD;;6KD)_VZ/VB8?!'@GXF1R3:GJWA-
M=1TCQ+HMAX6N+ZV\36[^*]'TZ&5(8Y4SKI]XUTCQ$K)L)4B)FH _4#P!9ZY
MIW@;2(/$U_INJ^(H;.)-3O=/LGLK2ZN0@$DD4+R2M&C-DA#(Y (&X]:UZ_*#

M1RR[O.Z2T_X*;_'GQ5X?^+KA-'\




+_ AZ+\B_^W-9S:A^

*-XGU8



MWVBCFH_RO[U_D&IX%_P\Z^O_0T:M_X2VK__ +1_P /.O@K_P!#1JW_ (2V
MK_\ R+7OM%'-1_E?WK_(-3P+_AYU\%?^AHU;_P );5__ )%H_P'G7P5_PA
MHU;_ 
);5_\ Y%KWVBCFH_RO[U_D&IX%_P /.O@K_P!#1JW_ (2VK_\ R+1_
MP\Z^O\ T-&K?^$MJ_\ \BU[[11S4?Y7]Z_R#4\_P'G7P5_PAHU;_ 
);



MHJG67M.=+2UM_*V]OTSL?.O_#U3X+_]!+QY_P&X\2?_(%'_#U3X+_]!+QY






M]4^_P#T$O'G_AN/$G_R!1_P]4^_P#T$O'G_AN/$G_R!7T511S4?Y7]Z_R#


?@S_T

M/
?@S_T

?@S_ -#'K7_A
M*:O_ /(M'_#S'X



end













							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











Nov. 30
 2016
Feb. 28
 2017
May 31
 2016



















































































Entity Common Stock
 Shares Outstanding



000
000

























  2016






































If the value is true
 then the document is an amendment to previously-filed/accepted document.

























































This is focus fiscal period of the document report. For a first quarter 2006 quarterly report
 which may also provide financial information from prior periods
 the first fiscal quarter should be given as the fiscal period focus. Values: FY
 Q1
 Q2
 Q3
 Q4
 H1
 H2
 M9
 T1
 T2
 T3
 M8
 CY.




























This is focus fiscal year of the document report in CCYY format. For a 2006 annual report
 which may also provide financial information from prior periods
 fiscal 2006 should be given as the fiscal year focus. Example: 2006.




























The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data
 it is the date up through which that historical data is presented.  If there is no historical data in the report
 use the filing date. The format of the date is CCYY-MM-DD.




























The type of document being provided (such as 10-K
 10-Q
 485BPOS
 etc). The document type is limited to the same value as the supporting SEC submission type
 or the word Other.

























































Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests
 if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member]
 Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings
 Instrument.




























Indicate Yes or No whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports)
 and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.




























Indicate whether the registrant is one of the following: (1) Large Accelerated Filer
 (2) Accelerated Filer
 (3) Non-accelerated Filer
 (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.




























State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold
 or average bid and asked price of such common equity
 as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.




























The exact name of the entity filing the report as specified in its charter
 which is required by forms filed with the SEC.

























































Indicate Yes or No if the registrant is a well-known seasoned issuer
 as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K
 10-Q
 8-K
 20-F
 6-K
 10-K/A
 10-Q/A
 20-F/A
 6-K/A
 N-CSR
 N-Q
 N-1A.


































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }






Nov. 30
 2016
Nov. 30
 2015











527
624


886





053







221


480





332


887





879
230


253



Intangible Assets - Licenses
 net

425
000







304
230


253












612


680





178


024



Loan Payable - Related Party
 net of discount $8
812 and $0
 respectively

188


000



Loan Payable - Third Party
 net of discount $18
135 and $0
 respectively



000



Convertible Debt
 net of discount $0 and $147
230
 respectively



152
770





978


998
474



Convertible Debt
 net of discount $1
285
836

114
164







843
142


998
474










Common stock
 $0.001 par value
 300
000
000 shares authorized; 31
000
000 shares issued and outstanding as of November 30
 2016 and 28
000
000 as of November 30
 2015
 respectively

000


000





431
976


177
540





786)


643)





936
102)


800
118)





538
912)


609
221)





304
230


253




































Amount due from customers or clients
 within one year of the balance sheet date (or the normal operating cycle
 whichever is longer)
 for goods or services (including trade receivables) that have been delivered or sold in the normal course of business
 reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.




























Carrying value as of the balance sheet date of obligations incurred and payable
 pertaining to costs that are statutory in nature
 are incurred on contractual obligations
 or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes
 interest
 rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).




























Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital
 capital in excess of par
 capital surplus
 or paid-in capital.

























































Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash
 sold
 or consumed within one year (or the normal operating cycle
 if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
























































Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.




























Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares
 par value and other disclosure concepts are in another section within stockholders' equity.




























The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.




























Carrying amount of long-term convertible debt as of the balance sheet date
 net of the amount due in the next twelve months or greater than the normal operating cycle
 if longer. The debt is convertible into another form of financial instrument
 typically the entity's common stock.




























Amount after amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.




























Amount after valuation and LIFO reserves of inventory expected to be sold
 or consumed within one year or operating cycle
 if longer.

























































Amount of liabilities and equity items
 including the portion of equity attributable to noncontrolling interests
 if any.




























Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle
 if longer.





















































































Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is
 noncontrolling interest
 previously referred to as minority interest).




























The amount for notes payable (written promise to pay)
 due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).




























Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle
 if longer.

























































Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest
 minority interest). This excludes temporary equity and is sometimes called permanent equity.





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }






Nov. 30
 2016
Nov. 30
 2015











812







135









230





285
836





Common stock
 par value (in dollars per share)






Common stock
 shares authorized

000
000


000
000



Common stock
 shares issued

000
000


000
000



Common stock
 shares outstanding

000
000


000
000



























































































































Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued
 repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners
 and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

























































Amount of debt discount to be amortized within one year or within the normal operating cycle
 if longer.




























Amount of debt discount to be amortized after one year or the normal operating cycle
 if longer.





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015











042


569





738


951





304


618





681
358)


511
893)





611
054)


505
275)












073)


549)





073)


549)





187
127)


169
824)





135
984)


155
181)





143)


643)












696
721


000
000

































































The aggregate total of expenses of managing and administering the affairs of an entity
 including affiliates of the reporting entity
 which are not directly or indirectly associated with the manufacture
 sale or creation of a product or product line.





























 -Subparagraph (SX 210.5-03.1
2)




















































































The portion of profit or loss for the period
 net of income taxes
 which is attributable to the parent.

























































The aggregate amount of income or expense from ancillary business-related activities (that is to say
 excluding major activities considered part of the normal operations of the business).





















































































The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.




























Aggregate revenue from the sale of minerals and related products
 and from rendering services such as exploration
 development
 mining
 processing and providing mining support activities.
 -Subparagraph (SX 210.5-03.1(a)
(d))



























Number of [basic] shares or units
 after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding
 determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }













Balance at Nov. 30
 2014

000


000


937)




937)



Balance (in shares) at Nov. 30
 2014

000
000




























887






887







653






653









155
181)


643)


169
824)



Balance at Nov. 30
 2015

000


177
540


800
118)


643)


609
221)



Balance (in shares) at Nov. 30
 2015

000
000








000
000




















366
667






366
667





000


697
000






700
000





000
000















994






994







775






775









135
984)


143)


187
127)



Balance at Nov. 30
 2016

000


431
976


936
102)


786)


538
912)



Balance (in shares) at Nov. 30
 2016

000
000








000
000



























































































































The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.






















































































Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP)
 net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock
 the exercise of stock options
 stock issued under employee stock purchase plans
 and/or other employee benefit plans.




























Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest
 minority interest). This excludes temporary equity and is sometimes called permanent equity.





















































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015











187
127)


169
824)














250





025


657





000







994


653












053)







446)


838)





741)


480)





086


186





480
262)


204
396)












000)


070)





000


000





000)


000)





000


000





100
000


300
000





820
000


391
930





339
738


534





886







527
624


886












366
667


887





700
000







775





















611


250



































Amount of debt issuance costs (for example
 but not limited to
 legal
 accounting
 broker
 and regulatory fees).


















































































































The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense
 this element is added back to net income when calculating cash provided by or used in operations using the indirect method.




























Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.




























Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

























































The amount of cash paid during the current period to foreign
 federal
 state
 and local authorities as taxes on income.






















































































The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity
 associated with underlying transactions that are classified as operating activities.


















































































































Amount of cash inflow (outflow) of financing activities
 excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on
 and a return of
 their investment; borrowing money and repaying amounts borrowed
 or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
























































Amount of cash inflow (outflow) from operating activities
 excluding discontinued operations. Operating activity cash flows include transactions
 adjustments
 and changes in value not defined as investing or financing activities.




















































































The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.

























































The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle
 if longer.




























The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.




























The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates
 owners or officers and their immediate families
 pension trusts
 and so forth. Alternate caption: Payments for Advances from Affiliates.




























The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle
 if longer.




























The aggregate amount of noncash
 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016










 &#8220;our&#8221;
 &#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&#160; The Company was formed to engage in the acquisition



 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation
 organizational development and execution of its branded and private label consumer products and ingredients business plan.



































The entire disclosure for the nature of an entity's business
 major products or services
 principal markets including location
 and the relative importance of its operations in each business and the basis for the determination
 including but not limited to
 assets
 revenues
 or earnings. For an entity that has not commenced principal operations
 disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016























 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products&#160; Inc.





 &#8220;Earnings Per Share&#8221;
 specifies the computation




















 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include



























































 more likely than not







 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets





 on a periodic basis
 long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators
 such as the nature of the assets
 the future economic benefit of the assets
 any historical or future profitability measurements








 which is not bifurcated and
 accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any





 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value







 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including quoted forward prices for commodities
 time value
 volatility factors
 and current market and contractual prices for the underlying instruments



 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps










042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products
 we adjusted fourth quarter revenues downward by $94



 product is shipped or delivery is complete (depending on the terms)





738. Cost of sales was adjusted downward by $49





 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award





 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)










 in the opinion of management





 controls
 is controlled by



 its management



















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 through the issuance of a secured convertible promissory note. The investor has agreed to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate). On November 30
 2016 the Company had $1
527
624 in cash and has access to $5
900
000 available from the investor. The Company feels this represents substantial liquid resources (cash &amp; available financing)
 sufficient to meet the Company&#8217;s obligations for the next twelve months
 and as a result
 the going concern disclosure is not warranted for the year ended November 30















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125
000 stock options to its president
 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5



 2015
 Michael Browne&#8217;s stock options were amended to 625



 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1



 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options will expire on December 31
 2016 unless exercised. The total outstanding stock options as of November 30
 2016 are 2
358



703. In 2016
 the Company expensed $111
993 as compensation expense compared to $482
653 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5





















































875






































































































































375












































































































































358




























666

























 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43



 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
000 secured related party promissory note. The relative fair value of the warrants is $35
250 which is recognized as debt discount. As of November 30
 2016
 $26
438 of the debt discount is amortized and the unamortized discount is
 $8






























































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016













 2015
 Continental Ingredients Canada
 Inc. (&#8220;CIC&#8221;) of which the Company&#8217;s previous CEO owned a significant interest
 loaned the Company $180
000 bearing interest at the rate of 8% per annum
 payable on maturity



000 note was advanced during the year ended November 30
 2015. The full amount of the loan and accrued interest of $13
177 was repaid on September 27



 2016
 the Company entered into a Securities Purchase Agreement with CIC whereby the Company received proceeds of $200
000 on March 4
 2016 in return for a $200
000 secured promissory note due 12 months from the issuance date
 bearing interest at the rate of 10% per annum
 plus 100
000 warrants to purchase common shares of the Company at an exercise price of $1.35 per share for three years from the date of issue. As of November 30
 2016



 the company purchased inventory from Continental Ingredients Canada
 Inc. The total amount of inventory purchased in 2016 was $316
086 compared to $291


















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 one for $200
000
 one for $100
000 and the other for $250
000 bearing interest at the rate of 8.0%
 8.0% and 10.0% per annum respectively
 payable on maturity
 calculated on the principle amount of the loan outstanding. The loans for $200
000 and $250
000 were repaid on September 29
 2016 and the loan for $100
000 was repaid on October 4















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures



800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14



 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30



 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2016



 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities&#160; purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26



 without limitation



 the Company will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance





 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1
366
667 which was recognized as debt discount. As of November 30
 2016
 $80
831 of debt discount was amortized and the unamortized discount is $1
285







































The entire disclosure for information about short-term and long-term debt arrangements
 which includes amounts of borrowings under each line of credit
 note payable
 commercial paper issue
 bonds indenture
 debenture issue
 own-share lending arrangements and any other contractual agreement to repay funds
 and about the underlying arrangements
 rationale for a classification as long-term
 including repayment terms
 interest rates
 collateral provided
 restrictions on use of assets and activities
 whether or not in compliance with debt covenants
 and other matters important to users of the financial statements
 such as the effects of refinancing and noncompliance with debt covenants.
 -Subparagraph (SX 210.5-02.19
20
22)








































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30



 the net value of the license was $2
425
000 after amortizing $275















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2013
 the Company entered into a Deed of Assignment Agreement with Everlast World&#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights



 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary



 or arising from its termination



 as per the terms of the agreement
&#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016



















































313









825

































859



















859







































 2016




 the Company has recorded a





































The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position
 net change during the year in the total valuation allowance
 approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets
 utilization of a tax carryback
 and tax uncertainties information.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016











 2017
 Trident Brands Incorporated entered into a Letter of Intent (the &#8220;LOI&#8221;) with The Activation Group
 Inc.
 an integrated marketing and advertising agency incorporated in Ontario
 Canada.&#160; Pursuant to the LOI
 Trident will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200
000 cash
 and $800
000 payable in common shares of Trident.&#160; The cash consideration is inclusive of a $50
000 deposit paid to The Activation Group upon execution of the LOI
 and $150
000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200
000 installments
 subject to the achievement of earnings targets.&#160; The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence by the Company



 on February 15
 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated





































The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue
 purchase of a business
 settlement of litigation
 catastrophic loss
 significant foreign exchange rate changes
 loans to insiders or affiliates
 and transactions not in the ordinary course of business.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016






























 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products&#160; Inc.










 &#8220;Earnings Per Share&#8221;
 specifies the computation








































 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include


























































 more likely than not







 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets










 on a periodic basis
 long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators
 such as the nature of the assets
 the future economic benefit of the assets
 any historical or future profitability measurements













 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any










 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value







 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including quoted forward prices for commodities
 time value
 volatility factors
 and current market and contractual prices for the underlying instruments



 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps















042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products
 we adjusted fourth quarter revenues downward by $94



 product is shipped or delivery is complete (depending on the terms)










738. Cost of sales was adjusted downward by $49










 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award










 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)















 in the opinion of management










 controls
 is controlled by



 its management








































































































Disclosure of accounting policy for basis of accounting
 or basis of presentation
 used to prepare the financial statements (for example
 US Generally Accepted Accounting Principles
 Other Comprehensive Basis of Accounting
 IFRS).




























Disclosure of accounting policy for cash and cash equivalents
 including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents
 (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk
 (3) the classification of any negative balance accounts (overdrafts)
 and (4) the carrying basis of cash equivalents (for example
 at cost) and whether the carrying amount of cash equivalents approximates fair value.




























Disclosure of accounting policy for salaries
 bonuses
 incentive awards
 postretirement and postemployment benefits granted to employees
 including equity-based arrangements; discloses methodologies for measurement
 and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.
 -Subparagraph (b)
(f(1))



























Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements
 including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example
 common stock
 a partnership interest or other means of exerting influence) in other entities
 for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions
 noncontrolling interest
 and the income statement treatment in consolidation for issuances of stock by a subsidiary.




























Disclosure of accounting policy for recognition of costs in the period which correspond to the sales and revenue categories presented in the statement of operations. The accounting policy may include the amount and nature of costs incurred
 provisions associated with inventories
 purchase discounts
 freight and other costs included in cost of sales incurred and recorded in the period. This disclosure also includes the nature of costs of sales incurred and recorded in the statement of operations for the period relating to transactions with related parties.




























Disclosure of accounting policy related to debt. Includes
 but is not limited to
 debt issuance costs
 the effects of refinancings
 method of amortizing debt issuance costs and original issue discount
 and classifications of debt.




























Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors
 including any antidilutive items that have been excluded from the computation and takes into account stock dividends
 splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.






















































































Disclosure of accounting policy for income taxes
 which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances
 recognizing investment tax credits
 operating loss carryforwards
 tax credit carryforwards
 and other carryforwards
 methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

























































Disclosure of inventory accounting policy for inventory classes
 including
 but not limited to
 basis for determining inventory amounts
 methods by which amounts are added and removed from inventory classes
 loss recognition on impairment of inventories
 and situations in which inventories are stated above cost.




























Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes
 but is not limited to
 quantification of the expected or actual impact.




























Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances
 and when impairments
 charge-offs or recoveries are recognized.




























Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions
 the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example
 delivery of multiple products
 services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016
























































875





































































































































375













































































































































358





























666






































































































































































































































































































































































































Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year
 vested and expected to vest
 exercisable or convertible at the end of the year
 and the number of share options or share units that were granted
 exercised or converted
 forfeited
 and expired during the year.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2016

















































313









825

































859




















859









































































Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position
 including the following: the total of all deferred tax liabilities
 the total of all deferred tax assets
 the total valuation allowance recognized for deferred tax assets.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015











042


569





738


951





040







308










































































































































For an entity that discloses a concentration risk in relation to quantitative amount
 which serves as the benchmark (or denominator) in the equation
 this concept represents the concentration percentage derived from the division.

























































Aggregate revenue from the sale of minerals and related products
 and from rendering services such as exploration
 development
 mining
 processing and providing mining support activities.
 -Subparagraph (SX 210.5-03.1(a)
(d))

























































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Sep. 26
 2016
Nov. 30
 2016
Nov. 30
 2015















000


000























100
000









900
000









000
000











527
624









900
000




























































































































Amount
 before unamortized (discount) premium and debt issuance costs
 of long-term debt. Includes
 but is not limited to
 notes payable
 bonds payable
 commercial loans
 mortgage loans
 convertible debt
 subordinated debt and other types of debt.




























































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015
Nov. 30
 2014













375
000


875
000







334









000


000
















667


000







358
333


375
000


875
000





666
667


334
























































































500











Represents weighted average remaining contractual term for vested portions of options outstanding and currently granted or convertible
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






















































































For presentations that combine terminations
 the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.

























































Number of options outstanding
 including both vested and non-vested options.












































































































































































Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Weighted average remaining contractual term for option awards outstanding
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015









Outstanding - November 30
 2015






Exercisable - November 30
 2015








000



















Outstanding - November 30
 2016

000























































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }













Mar. 04
 2016
May 05
 2014
Jun. 01
 2016
May 01
 2016
Jan. 29
 2016
Nov. 30
 2016
Nov. 30
 2015
Nov. 30
 2014

































358
333


375
000


875
000















703



















000


000

















666
667


334




































994


653

















025


657








































































526











000








000





































































































































000





















526


































































000



















250





























438



















812







































































































































































































































































































































































































875
000








375
000




































































125
000










000















































000

























































000

























































000

























































000

























































000

































































667



















333











000



























































000


000

















  2021


  2021



































































































































000


000






















































































































































000


000














































































































Value of options outstanding
 including both vested and non-vested options.






















































































Number of securities into which the class of warrant or right may be converted. For example
 but not limited to
 500
000 warrants may be converted into 1
000
000 shares.

























































Amount
 after accumulated amortization
 of debt discount (premium).

























































Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example
 but not limited to
 weighted average cost of capital (WACC)
 cost of capital
 cost of equity and cost of debt.




























The aggregate amount of noncash
 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.




























Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition
 market condition or a performance condition
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Date the equity-based award expires
 in CCYY-MM-DD format.




























The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends
 if any
 over the period.




























For each plan
 identification of the award pricing model or other valuation method used in calculating the weighted average fair values disclosed. The model is also used to calculate the compensation expense that is shown within the balance sheet
 income statement
 and cash flow. Examples of valuation techniques are lattice models (binomial model)
 closed-form models (Black-Scholes-Merton formula)
 and a Monte Carlo simulation technique. Fair value is the amount at which an asset or liability could be bought or incurred or sold or settled in a current transaction between willing parties
 that is
 other than in a forced or liquidation sale. May include disclosures about the assumptions underlying application of the method selected.



















































































































Number of options outstanding
 including both vested and non-vested options.

























































Period from grant date that an equity-based award expires
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Expected term of share-based compensation awards
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






















































































































































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











Mar. 04
 2016
Sep. 26
 2016
Feb. 29
 2016
Nov. 30
 2016
Nov. 30
 2015




































000


000



Loan Payable - Related Party
 net of discount $8
812 and $0
 respectively







188


000

































100
000









Continental Ingredients Canada
 Inc.






































Loan Payable - Related Party
 net of discount $8
812 and $0
 respectively









000











086


385



Accrued interest expense repaid on September 27
 2016









177



Continental Ingredients Canada
 Inc. | Securities purchase agreement | Secured convertible promissory note








































000













000











































000









































































































































Number of securities into which the class of warrant or right may be converted. For example
 but not limited to
 500
000 warrants may be converted into 1
000
000 shares.




























Contractual interest rate for funds borrowed
 under the debt agreement.




























Amount of interest payable on debt
 including
 but not limited to
 trade payables.




























The amount for notes payable (written promise to pay)
 due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).









































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }



















































000


000










































000




















000



































000


















000





































000




















000









































 -Subparagraph (SX 210.5-02.19(b)
22(b))



























The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle
 if longer.




















































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }












May 14
 2015
Feb. 05
 2015
Sep. 26
 2016
Jan. 29
 2015
Nov. 30
 2016
Nov. 30
 2015



























100
000


300
000













366
667


887













025


657













285
836















000


000







































100
000


300
000









000


800
000











Common stock conversion
 shares







239
437






























442













366
667


888

















831















285
836











  2019















100
000















900
000















000
000


































































































































Amount
 before unamortized (discount) premium and debt issuance costs
 of long-term debt. Includes
 but is not limited to
 notes payable
 bonds payable
 commercial loans
 mortgage loans
 convertible debt
 subordinated debt and other types of debt.



















































































































Contractual interest rate for funds borrowed
 under the debt agreement.

























































Date when the debt instrument is scheduled to be fully repaid
 in CCYY-MM-DD format.




























Period of time between issuance and maturity of debt instrument
 in PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Amount
 after accumulated amortization
 of debt discount.

























































The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.




























































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Jan. 06
 2016
Nov. 30
 2016




















425
000







000



















000
000







700
000



































































Useful life of finite-lived intangible assets
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Accumulated amount of amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.

























































Amount after amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.


























































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015
Nov. 30
 2014
Nov. 30
 2013













Net Retail Sales
 percentage










Direct Response Sales Revenue
 percentage










Direct Response Sales Revenue
 percentage description





















Direct Response Sales Revenue
 percentage in 2016 onwards










Direct Response Sales Revenue
 percentage description in 2016 onwards












000


000


000







000











000











 as per the terms of the agreement
 are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the previous Year's Annual Minimum Guaranteed Royalty plus 10%
 whichever is greater.















































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2016
Nov. 30
 2015











313
340


825
245












859
669


836





859
669)


836)












































 -Subparagraph (b)
(c)

















































































































Amount of operating loss carryforward
 before tax effects
 available to reduce future taxable income under enacted tax laws.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }






Nov. 30
 2016
Nov. 30
 2015











313
340


825
245



































Amount of operating loss carryforward
 before tax effects
 available to reduce future taxable income under enacted tax laws.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }





SUBSEQUENT EVENTS (Detail Textuals) - Subsequent event - Activation Group
 Inc
















000





000





000 installments
 subject to the achievement of earnings targets.










000















000















000

































































Stock payments payable in four installments
 subject to the achievement of earnings targets.




























Amount of equity interests of the acquirer
 including instruments or interests issued or issuable in consideration for the business combination.

























































Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure
 which is further associated with dimension and member elements pertaining to a subsequent event.
















































































































































begin 644 Financial_Report.xlsx
M4$L#!!0    ( 'F*7$H?(\\#P    !


WX5.\    K @  $0   &1O8U!R;W!S+V-O


MK1.!^ 8^Y?/GR4W*@CE([Y$'S2P70SV

G'
UZK&1\^8Y=A6@%V
M:-%1 EYR8.TT

M7'_X786MUV9G_K'Q1;!MX-==M%]02P

M !




B0103 9IZ_PP JE3%ZU6FD PSA]R1
2
(<7<K_WUE[O)



9:AAOBTQJP1X!-]M[X(


MCVFS(Z=T)LWH







M\J(A[J&&F


O




MP2!^5_0A1NU IW)D[$5WOIU78:QG1&MZDCH$48\[W=&ZUI'4//[:H.&@J8GC


/_!Z28D:VP4-96&O/;/JC7/1_\F*RP-)F!+P 
!YY\2$DM(!@)*/R6D


J)G
#T%
MZ:FAIR-Z[BR1CRA@@0P4R#SZS!'H$9E!M/TW2#&:QQ





BYX;6Q]E]MNXS80AE]%T'U6G.%!5& ;:%P4
ZTC7^QSWJ(6!4_%6X:[<XCX967IKF^W#QVW$;


M_



*G(VA&=@ ZE
 8(HQB=
M569ME@-/*D#J2(:.D'G* *D-'5$=6! +)-T[XMD'%'XJA-^LN:N4 5CBB-%9

M T]UF&56I6LCSV
.*.=4R#F@ -




IIS;.QV_1/YGB53%[+
B6T5_U45:K
ML B#(SGAY7/K/],QH+2,!BK_TJNAJY)E$Y#HP*\PP.%R%9
T91* U^'=YU

[H!D7I#



:
MN^P.67_J5+GS1DV=$81XUI15FZX6?N^A6RWTV=15JQZZI#\W3=G]6:M:7Y8I


MKXK

M.]2 2Y2'F4 R-G'V#H:!

M&/$POI 0H88$0PF*DB(GH-1 [;8P3W A3GQ
)F@&)6)C@*D]] 0LYSEL^\
M#7BF/^&8B8=



M\XN?
O9:&V5!T:U%/-K!\[JHU=ZX6V'ONV'Z&A9&G\;)
KN.MZN_4$L#!!0






MU10.WBEQ8VQMT?3_T?:E:6TY6G%2RNS7\
RK_GD:O@@UTG &0GD3 !ZE4!'
M CT3B+Q*8.!O1'2JP0^$O@;@5TEB)$@WGP@_7P



M#-1(S^D'&0PSH\ Y*^(:P0(3#!?-FI/:$48+ERAPE481F^@E?I0\JE #H4


M?&]M:YS5]).S=W#7Q'.C

$%
L-$-*H@+;0.S%H@5:(-ABVV?%IB]875Q)CK?_OM1E
MO19YF#S$NAS.G&I3Q27M[KYWIZT[A8_RJ)J5\&IZR[/8=CN3KK
VT_U15?F





FFK0/ E2*7%J50.%2:988DLQM!2#F@0.D

M24TF3]D9S).!/-9$V&1.'B+*
GL07)E4G


LY4@YO01T4M&#;FX)0XEB8(EL2[%;/IOB
0*ZV(\]PMPC #YR*.$B[6E(Y7@0F+A-<48?AP!4_;3.XGF


M+W-H965T-RYX;6Q]4]MNW 0_17$!P0OWJ3IRK:4356U4B.M4K5]9NVQC0+&
M ;Q._KX#=ERKL?(S'#.F0M#-AK[Y%H 3UZTZEQ.6^_[ V.N;$$+=V5ZZ/F
M-E8+CZ9MF.LMBJ2M&(\26Z8%K*C119])UMD9O!*=GRQ U:_MZ!&7&G.[H
D2
A#7YS?UK[%VK.4L'-P;
M]4=6OLWI+245U&)0_M&

*IJ+%

CAC

MVP+[38%]%-A_6.(&)OV_2+;JJ0;;Q&ERI#1#%R=YY5T&]BX^(OL'GZ;]0=A&

MVS#76Q!5!&G%^&YWP[20'2VRZ#O9(C.#5[*#DR5NT%K8WT=09LSIGKXYGF33
M^N!@1=:+!KZ#_]&?+%IL8:FDALY)TQ$+=4[O]H=C&N)CP$\)HUN=2:CD;
Q+
M



?&=;YCAX)0V<+7&#UL+^/('L: 9?7


M%%0^





M9CHM)F.?7 _@R;.2VI6T]WXX




KXAV*=^B]58?L6+!;(%IB
MSG-

E?
M2=BFIPIL%Z?)D=J




4C ]-20]!$$BH?6#@N-W@
M :0



\H)3#'8Y0CQ]L

_17$!RPS
M3/:B41)I9ZNJE5IIM%7;9R9Q$K2 4R3[=\72#9-VZ@O@(W/\;$Q^8CVQ74
MGKQJ95Q!.^_[(V.NZD +=X,]F'#3H-7!].VS/461)U 6C&^V]TQ+:2A99Y\
C@Y5Y+UKX OYK?[;!8@M++348
M)]$0TU!'_?'4Q;C4\ W:-;G4FLY(+X$HV/=4%W41 HJ'QD$&&[PA

:[G/LIQ=(]$<<YIB^#IFB6!

MI





]GRB9BO\.%U 8
M'I1@CL(H%U=2]

Y_^2L$5/-=@Z3I

M.

MVW'
1L.;;OI!;/[&^5]02P

  !D   !X
W
MF\-Q%^)CP\!@UN<2:CD;
Q3


F%I2B^/.XQWW8;S9;R?8.B= .D
N(EYV)@H*O_
/2\R:P9B

F:.8
@^ITC74AS3

D+[SS





^8CFV78 CKPHJ6U!.^?Z$V.V
:EGGT74R9X^DT' QQ Y*
M<?/K#!+'@N[IJ^-)M)T+#E;F/6_A*[AO_<5XBRTLM5@K4!-##0%O=^?SEF(

G[.G'1)&8#K\RO[


O WB?Q




M#'9Q)J&2
^)K

P.7YD_TQUNYK
M.7
<7BJ9YK2J;BO\(%I \/2GR.$J6-*RE[ZU!-
M+%Z*XN_C+G3<A_$F32?8.B9 
D
V

X$#

MFS(X8ROBG1=OO?=2;*]O
G8)1%/

/3585I
8I<2G8&:X2U 0  T@,  !D   !X;]W;W)K<VAE971S
M+W-H965T




P(YM7G$'PMQ)%_H/-U^G8UPVVD;Y?1

MII:M)6=T_F5C_RM$!SZ5Y
J/4.
_V&PHJ%PX?O%G

M2P

M$O=52

?W#]L]U)



__$-%LO


H




LR'8 BH\MRU&P0J/'Y#L!<04.B%ZS@0Y+$<BMV @DHO

M^R[N.Y/GLE'!7FC3L-BVXB2$YB:7^

=)Q4^Z&V9F+/ONJ9]HT0Z=


!#]*Y9_0)U LJ81(#6MJDW:I*C3VL\.




[[GC66)T3\S0^Y;[*U[O

D[?H/6?KF^N$G3W1B#D
F&B.F1 




V?2OR-X!4$L#!!0    ( 'F*7$H2359&M@$  -(#


MK7I7T

G%F)=@?*X+FH2$0$'E@X+ [0I/H%00PC1^

-D[X*P34\UV#9.






7
_EZ7/O ***
%LI $/VZ


)!H
MG3BU#6S_OK:3#;D86AZ([9S+S(!GTBOC;Z( D



M@D'\+.$J!FM'I[)G[$UOOAQ6KJ\C @JYU!)$/2ZP 4JUDHKC=R?J]IZ:.%Q_




MV 5JT!H!,*1P&*21HN)#:9N,;[^3'*QP*)H!N%$UG#B2SA+.TL54@_O^




RYX;6R-5]N.FS 0







MV[0QJ$?:!LQ@J38:5,C8SSIB0.EZEFPC*


HFR








MFR%9&DF64Q)W%&*W?+H=CQ0#B- ($1H@X @B? KQ2#& 6!DA5H:#L1Q!K%[[


MEW+
FM;;3 2MVFL%Z.XV\3]02P



BNW198^M8W6
MJYE

_SMVJUW&3WQ:1\6Z_3XK^+;)5_G$W%]/.+'\N7
;&[!O98'US7P!W;P'<-_+$FA:Y!
MB!K


M)DWNFVA.1:8$ZW#K27C-O\B\)\076A6=6(O#LJ8RQVT&('+(Z&N-UI_.$0

H^X78


-UTHD-LARJR
 B8#XA9EHC ./%VHL.AZO7CV) 85$GQ J'B:<VW6GEF)$RA1!22
M4*';!N\%DP@59E6!38


KDUC
M0#4JHR1*@
@SI4UCBC4 E+L'T!A0'8Z/$H/9
^BP'!TT+CO1T%57=X
$A&K@
M3LQ@4 U@

CQUQ;6\Q/A9=2Q&'Z5%PT&&
F068!:8J6TR%

S%-SH/$H?!U??0%3NFQP)Z E



M&T@*'A/M4=W4L466++0XB1\R7G^GZIN#LX.GV4$EW!PS3W%'U%:/&?2HMI+H

M&PC]@'D.J/3&H=^)^D$=1_XWHKXQ.#
$4)RYJ_: 40XCBG/ ^(4CWL:X#/1-

#FI


MDO#V[6ZR+PG3DRC?JSWGTOK(TKR:V7LIBT?'J=9[GL75@RAXKMYL19G%4G7+
MG5
5)8\WM5&6.NBZ@9/%26[/I_782SF?BH-
DYR_E%9UR+*X_+/@J3C-;+#/

\KI!I@QKQ
^&G
';^)#*5W'ZS-N$F&VUV7_E1YXJN(Y$^5B+M*K_
MK?6ADB)K650H6?S1/).\?IY:_K,9;8M 5X


^WY



M='





MN2BH^+=D.:\7/O@?R_9\:3,0I#.*WIDOYAZK39SX*699\5K)09+SW!#@O_



M$8X08021)8@[A

AB2HLA2:A_/3&W
 @[L$XY
5I.C)0SZ9738)*K

!^SY^';/'VSF!




MAE%0I%GISR;MW%



MTDEP:@P9S$.'P3T
ZV/F$;J8Q8N!B,+\PC9B?N8)6GCU@!5CX@@2[(I2H8







!)Z7D)YV


=6IHZ(6I)SY]

MP9K@1_]


,H(/VJBN/.3[B5?CLG$7F5[;LD5&SZ(J&[)E#C_7-69_
M<U+1Z]P-W-O:WDJA%KP%EF+3^0G$6_MELF9U[



M%T5D
'F'00-

P&:$F

@+Q6%G;0#PQ'% 
!A0#!):S.81)

M77( 9E!R(Y$)*#(!1*QZS '
HZV9@B)30
3ZQ'
 


I\






M)*T:V'-/7.J:\+];H*S;^*'_$7BISJ74@2#/6G*&GR!?VSU7NV!P.58U-*)B




$RGTH@5PEMFB6CNX+[.8*C-P5L+
);/+Q71/_





M!IC


MB:CBK CV
H^##.

M-3)_)[(-=8?9^&8XN[#FTAK7/=7T[J[$)R\4

M(!==D

EH)#9_WTQLWU?-GFPJHQ

M:&5E='


M4RDZ3_:'WS+[CNDJ-&=3V$5W%&[/!*_

&PO<VAA<F5D4W1R





M





]V+EH



MP
M'CJH(LPK8^:UV^_U^P-O#23\*8@*Y0/Q]/T^_\_+F+4%17Z?I.'?U.('E)FU



A)%F[0:$XU7L);753^A.\L


/@3IPJ'ZUTD*-90OR'NFJ' .%=@+0)R-?#<1JT$
MB)4941M9MX#

MG&\Z6#X:


G:




%; &-L5[:OKVS-OT/.V78+G.I23=)VD1$PO

^H6'KT;! XDE_)L$%1G[ZE.P)BC-D_1D'7


IHSYL8







R

ZIQJK:@TK=$3S&ZB9
05JPI


*

MI62Y)P

M
L05-5S N'W0B(M^^11.




QSHU708GYH_KYT/Y ^_SDG2P?Q





0Z*



9L5&$%@J%1@5@8V+#8!)TO(@[XFS6T
/ZR(+6LE
MQJ@N%T^.

I);W.\PJ?%_S


.:$
M L'[EF !?'*O4O&^!)4@F'TF$87Y2
D/7A6;@$DT0;YSMBR M_R-ASA.)7








MQ-.P7ZY8]0AM^SSN0\[='[_B-&Z;
L7++[)XS719Z9Z'G3V!Y%H]!'D'WO


*?B')!

MP2F:(Y/#; :0

O4CIGXLG1<B0!RR;EDME93'!!YP*L
EPI3;&


J6P
[#4Z*


M%0.R%_ F)% 

$ G72 )H72ITZJ3T%6J?$5C@WLN% H6?L$[6

OV28:;:
MY2A1#WT[P?PKHW]9
E=[#4TH3


?/.!F^HCV4



M5*G2Y!7[[+;V*Q)\*T@JD4_C
2]3:;3?T=)O&Q:+Y]G35Y1N

MQ.1FXJ1TB\-] +N55[9
TLJH0(YHJ$NH

M4D?+?]I





?'N(4;N3$Y.O??+4V5BPHLPV\UZXHB63E%G! 2EZLF%4
M$WRPLB#IIC89PWJ=M)
MF/1';=3BY[+N%29M2:CKDV*3 &D<

X+].C2
L:+
ZY*#W8EU5AB
MR@L6(QSM)ARV<WXK0VBKT11&C-('Q1%&$SU@F48:7

M=DZLM8M PI&C=&[K7HEHK=MJ2(25R?4YO%MZD30/5]&)UFP]?PK7GT ;_R
 ,)W]DH2'P\X..419A3A*6-V STWN'M&$*OZOSB
M54[G8<:X@CDHZ-/!(\G<^#;MCZXF\D=*._1!?1[A^-:4KD$2[6A.ACJK./6


OYNWL%

MM7UIKY&N+* EN/@49H3;-PE0-:P'F-.
(CDPU!^Q[HTW28&U!8#?30@*5F#(




#_

Z0<?Q



?#HYZHS$\.3B4_XZ!
MK%^P\+Q%BVO4@Y


MK8*8_'[GRMR)$]5XQU2(FLBUN3.MWF'

MQW:L\JDF[E]?R_Z.4:EV=G=0V]O9[XUWSBS&V/[I7G]OYPTSA9TARRX8I'=T
MO#/J[8_T(!S2_)D.FSXYP7
D;R#\?D:DMM@YE.^O*W6O'


&!OS\Z^GKH[G!=6[EW4K%S*6<G


VQLZ
MFF1




!!2
MIM7!06


G]


M9&3
[D$/9=T1

F]_@N?_I]&&?1[-C56

:3;=7E#+B
M:W?@'U6=]

MG6OL59476
B!1?&]YO21#A25V $GHAG
K.;X9:UPM-668+V.@'L+.*VK15*/
ME&KB2.X2K!F&/GHA%V9




MS8YB.=[@I=LJ

!



M;IWJ*^=V+GB51ID?4[V1P7AO


MFEUN1DE;(U?S.+(1J;*Q_C*]O_J N6T/7I58(NSDSG
2ZPW1GV^%(.)
J4






M6P.UJMER

M=E


::BV\?W.
M5:6R3ZI%#;9V=T9^R.@J]$^YLP-_2/0.(?[XQU<^PUL?&<TWGG!_\=]MANJ
M?^P


*K#:5@Y#)





9[;EK6
M7'.)!?2G=1JZQ!N
4B]UC8$@3 
D9&S &AXM/-



NPD0VCK_5V\


M^^MUKW5K2CTWLW6;V3J7YS:U



M]KG/[Z_0Y[>Q?^C+6W06N?

M]W+7.;$3[


MW*;VU2^V4[XVTP?PFIX1%1MUKOH+%OMU7-2E*'JAK($:/G9O[NK2=7#CB0
MZ!;$'5OP6F6T0U-2J



G7M


/T
M[Z(@1JVXBY=
H=)-IA'\\FQ\)XRS VV

MI+;/?HVE;(+K5\S1RF1;'_P:D_T#-]3*XEL?=#2 UCKT[68=^ES-VC7:U@;5
-3K







M&PC0Z;]0OO-=EN4__C]02P





Y=VO H7E33M=3O6[,<X7Q[=^!.04$WSM\4@P##3NJ:
M;=\Q6@H.?C&_+!@=63-25\'55+11\-GKTIF % 8K4%IFNTB7Q6IE[#1_77:
M%




M)BOS'-SC-[DY%*1E^LXNT043/-H?K?!H

MF%MOFS 4@/^*Q5/WL!&@=S657.)FEA*3@M
















E_*!3$Q&HU9;G0@'8:AS9'
)D]4RE4=!H^[\3;U-)'6UBJ7

MJ8+^A6;*4N54F'S5Q6IMXYDX2NBT-2IKZ2CXBTXI1=[WKETX44V,3';U.S'
MA/1R'&%;4S] %SEGY1O!?65Z@*[)S^IX.$VY

MJT QJT QJT QJT QJT QJT QJT QJT Q:X9BU@S%K!F*6;
+FK5KTT8J_1?)


O87!P+GAM;%!+ 0(4


M='

4
@,  )@.   8                3\5  !X





M='

YX;6Q02P$% 



4



4     !YBEQ*'RATB#4#  5#0  &0






M2P$% ,4     !YBEQ*26K@L (#  #V#   &0              @ $Q2P









2YX;6Q02P$% ,4     !YBEQ*SV7^I[D!  #8

R+GAM

S

M3A&'

N


#  #
%0





#$V
3$S


D(!OQMG


#SC3_4G(U:E^:$
M?]Z$7%AL6C$^\8$?


MQ)^%O@\LL.@[]6O.AQ:W\[^!'_#U=O9U_L

;[MW7 3YG\C?\*-6


2 ]E#]







%1^^CQPOWHH@Y4]N9S+C&OCX P^NYW7B=
P[VPJ9
M0^]?^5S0;)H%R\RN9N7S#VSBYK=RLIN'SV7.=879DY&6NOM)<L1 G*V4?-<



1J422Z\C4.1HNW@#[Q ?S- P&V/QS3<.:AHDDU[









]V]0OS9YAO

4ITV
MF5\9A@?[JLU1TBY

\DS!


MS+G'G*]MJ6?.^0=F2^V&\Q

M'*?-[.?)J=K









?FK!:




M]






)V%

.??59=
A[9XYQ+@9LOX5
M


*H1[X*!BI6Y
MTS2&



MPS^SY^9)Q\,B9TB ?GT5QX8J7D0D49:
$I\_TI\


$#L4-
MOK'S4XK@3 #P&:0;2J5^KWC
M9JN^


U?@#@%MHE?12T&:#TH&I4\B3YO'Q_UV+R50'Y9+3R-



M@+F1NT7P;6
KT^<V;S %A%0K_6)FP?


05TA#
M?QC$?KW=7!G&4T\$ET.Z.^D:#.GMH_#XN).QDC+3;P;9AI@[[O5:_95 ^\WW

N6@\2)XL!-.['&MDN%B]A=6V44



M /.R;[S\W=H!7F?$PMH@;GM]&RO
+#%OM+Y()D21Y ]
V.86]B@_V-V$U=1K
MC10+Y
)3!



+M)527








M/B] R

MV2YSS1*$1YJMX\9QNEW!9@#O=.D;;FFKWYSIP%S8TO/OQI GK+




MYOE6
E([1WS;0;_!5S1WHADFLSO)IND?H+!!]]M0&B 
2&]YU7 ;W!2 Y]

QQL_#U]]?,^,:?AG:W+&,/^!-G-TXA9=J
MOQ@_RZWN-YOUM_<\_J/QMF*D?O%?]%/P8A'EPG7OG%N&?L-.@P'YSW\#7
M'78O#&](_Z9



M(IQ


 K'1KMF) $]%(







*Y (UQ**UW-2*7;D3(IW=@%[-8S74Q1R6LE$Z]






@4UYPJ9:JY6!%C1WEE2K



N5#1($UK@^%2D&;6EJ45!]'-R9
M7NY


05
M+8L! L.QQS:E4'AOM$E= D)_A.C1V[&][9(#RA





M.4M8)CC/W2 =(R?Z=^V*_^B.H4#4

X&2 /LI39C[\A&


)L/TZ_3'!_XZ4#-@]N GVTP*6;WY4%)XOWG [9;!?' N_1QZ- /#A

L0[0T?%EL24?
M
*EER\ZD.(S$7)I9:A



F





Q
F&PHF0P^

)G!4V%0:3#(MSI:E[0-[&/IFU'/YY8NH0[-R*(6\U@-/
MT]0=!GSAR&28I*PT




2Z@G99P.IM0MD/GS2$A]238B^-M#






M(^
S[4Z6@;:T[MD+$2#9M9G2/57C*N9U


YA


MNT[.K6JN

NFB[
 UPU-.RI R4JV5)V61)VKR05\2)B'D3
M/J6@(:7J4 H/L1U8#H B]B:Z&$XF''N#Z$B?\JR9 *T_D!U/,'&Y$O,T_Q&





/O



8M?9)
MLF_]5!M0:H4@Q8S


MMZCICQ_ULY!E(+[4RU3

M@O(*)*T0RT!*FKG+QMR1

MI9NVK\=\/$B]9X^)D2D7!1.X\,O2T:-KUU*!J9'LCE5!?QMVI+DZFLQ1X0
MV!)

M/+H12UZQ2RZ$*FFC

MZH-0_V\IEBVK (J9L&&O_W
M;GPM1-SE1M2

;7@60+D


M?F
&EA/Y.+\







MHR&RO$9^$ 




M@8D5:&+=88=QU0\

YMF7%7Z-I5AF_4W]X_'[-
M. %;(


!A.4.+3ELWOER7B^

M[(;LA
5FO;ZXZ:1*


M;O#BLU8-1%2KUJD8[5K)W/B7+[2MH^52.7;D)M/X6UZG['

T\N;F%

)\-2+;WY_OK[; ^IX^M?F%6SW^2WG!84/(WCYKK$N*OM. =B



M5@$4$6=*;V#B%HWX(L7)(1'C-O;_U:/V?74J/R[%*K$\01-XZ0E\B]+VN%$&



(]/1WNT:18

M

MG@D9'G3:2-P



MK+0Z_4JKI0_5RT^
.FOD\5DCQZN+-$W@!RAMRY$UTJQU&L^##G7:2'%4AL9
M8MKCVJ,4DD:EV]W24Y9';J])L9]


M2H?K&F(/&CXF=P/N%V+WO.KT*IVEQ2H9V^]U@%;24B#E%L'RO7L!&_'6H!\#



%2 !C$OKF







O7C5JK(R4( Z3Z8WRK94PY\T7$@S  !_PH;H

):%%+AS)*AV'

A


MPLH]6-X\L/S;FED+9$6#RCHF^
M+'\*G/Q/9=9L$%DO;M



MQFWL_W.Y@JRUNNFO2?P I6TYKB!KU9Z+J'WRNV#W+&!15 V-#E+H($4)I($F


VQ5 !
RS;YV8



9AD##BC545O&RR@%WTP

:SK[F)BM0&M%V%



1@N$EK1FF%P


VC62!4W%]Y%T




M&^Z//_)!H$_##O4TK)LZ#3




D
/7@;VT


$7GT]UT@?% ^;0H0YR?=C
M**IIZ#QI:C3:ZBO-HB4@
VB9631?*UHX+GD$L68%]M
*T9U_FF[8 Z EI:C
7\^:]8 2&_6&3#)-9
' 3V\%.Q$)?I\W VF3BV

M+


MVZ3

MODPT0R

%DQA@K?2E::






M
U#SJA0
F

/HY'90]:B@C8WVA6D(-;

#
OT-LJ@Q6)RB0G*@+O$E$.9B-G -:/8?

MVJ41Y7B3B%7P+W@)C6GRQI;6%2T(IW?K23A=JZHR4)Q65663 ?L586U46MUN
MI=OM;1QC?=6O5_JM!OZ:C:O2L4T44HUS
4


[
M%EDR#I@[]M6H@8,9S45DJ[7I!4C7G7U

MQ9.F7Q^GTZ_/_CC[^OGD^L;X?'YZ=G%Z9IS\]O7L[

]

._/!]U5 HG=$!(V

&


MH+*)(.35F ^5EYVR .49.08+T

D$2^3.'*PUXWR8'=SB0Q8Z9&&IA!Y6 \FHDNM
MX%2:DDH'LREP21/++!X'_\CQ\

M%V1Z;I3TY4QG122!@%A3







=]_M8[JX=OY(Z?KF;]D=\L3%U






M.]7A!78H[U.MM3]?GJ?::/\BFZ=2=Q+LSB=E_V^^%TXJU(^N(F^]#OBMG Y;



6W



46WNN19X%ZSQM&\V\\S!C&,NW9&

5AKW$1!0F9:?K8VW#
@Y%GI:[EA1=F[==T)(X[
C#(LF=$



8UHYXV?
=OA%P

MN[/C6Y922- !\C)0I98399
34L]B9NEBEI7W]\C(AA0)\B@-=LRVHOA&WA#J
MC$RN$NW5.^ZS6W@W)-L7.'3FU#
YD$V'1#[:#DWY (3J2B#!QG17R8!6M?A]
M/


ME)S:KCU\NQ:WW$CMN39DM8(JW8Z424'-1E=L2H/ ;)(1@ 96HV
#-V%6T1T7

MIJO%

M[ND^\AU$@&);9I_60$L(N@5U$AUE@7*PN+S'-'


MW8 KC7$NXQ.7JYK1*CB85C%E(12M8DK&NNA5V&X F@(#15C@IC+G!PF3F0F3

GMZFY2U$7PV!C80_!'X@-;=;B+Y\.@O 0F


MLA-MS(=#;LK(&U6M@!)76CBZ%#V# QN+$P
J; 1%CQ?*REFX:T7WKZ.&]9D9

G)]6NTU^IDL@S0[5F4I8(9#DY2#6O1]E$
@%&B4@^!%*E/I&2'+_V(P
MN7]G8U.%6-?86
94HQU?E?]@WX=:%+0=#!&VN#/*4X3!G09$!$*V)[!O5N0'K
M5S&AP8J7.K? &((*F%0AQ3SP$<;<55RAA6S\5;2J:B& PM8Z\)S(U%
.TR
M.#V(5L:'KXR!*I+%?(;K9&U1B[=CI1-(Y_F:63 :?516CF3#!?EPG7JG6IG

$ OFEUJ4'J$MQYXT_(M
R


M RY4B%P:7*AJ+'2+^/$H*W8P+'%(.U:9TZLKG/?'

:][1:2;LE1*(GO!34S6C9JA@2*C,A!T
MR^9+NDJ VUIW;
8&<@ZAM%.^5*'H
M$DY)QFF4Z#GV+.Z02I1K2II82]
9-O


P*8#62Q6DB).\+20D!(WD80J-TLR
M]\1AF$(W\KWP=H09ZI20%3HRI2T2F0E?5PP3A/: 2V.*J[R\U.@@5!F*0\JH
M#R=*U XRLICD..5UY7@!\IX[%9Y)&E8*VE Y7R=QNO-@GX+?;259ER)%5E

M(+9R.VZDPQ0S1F/$S (VS@8G$ZT(]5-LER6L3Q66*7FC9-1_J]Q7X86^F=AD
M:AS

M%VAMK%*7DQCG2BDS*YW5I0_W?A?PZIF:4.A3O 

MS)1$
5R*?O.8WT@.3=MKDN%1I4:V7A%U '*XCR3Q=G^F51]2I!)3-/\K\)
M

D01!4/@9Y?6KYLX+*S6K0;#
%

A=0YERJF3TFME-72E)=!L6Q\N[''/#@GG
/$SG=&PO$N8 3


3AB5T)]66:T]RWS75H6U'F=14NDAQS&PW@/\?

M/^
0F*C@J#@GI3.1[#^[X[[#A#K
:_3:;^GEU$TUJ5\((I4_-0Q=4TTS]#ST
M?V]!5]DSPU^:'/;
N!SS6R8_UY9K&0A06ZYE$PE*;Y(11[=8W3-AO&IT^Y5Z
MNUDS;NX]PX0= )


\4L%
M#TU%R 0F+W$

7HH3
M.J


MNA[/$14U/_[AD

YPHN3


&M_FG
I)

R)Y+%=?U'KR@$7YBJW$Y?6BKMHO

MNO(]%_YI\E1]A/8[#M[O

M;X 0(KH9?





MTFFW)8






M481FI:4+AO:$&'7:R.



M'*\NU/;:D]UK B]5U&


KI[9KP8Z],8@8%4$<=WY:=P,]?S*X6DVAP=  E4Q8:;MWN)L

!L1UZ/5B29I3=(/DO0FK7YV
M2=*;Q8S*%R6*#! C8#\

M!VMNR5F*@.P:S!3*13LDS#3QNKV



S=X



M 1YH)

D2

MIPO9:9A;[_3J._W/T
W=Z?GGI=OI;?!THZZWNH1;O0VF/MBM+M9 ;G3Q?[T#

MLZW





ML#:

MO%'LN=].D9C*+ON38^(NMT[NN


\?J(T^R'Z;5+25[[@JKJ4/T\DB 9J%8



_)!7]X




_D([[6*2*S;


FY/K:X

MOS8;;$*@O]+PQT.AG(@XZ*

MX\I[


M/L

7IZ):A3)%UL!S7P:3R%@2+7KA

C#M[031

M2V838YCQ?$.UG

A?MXO
-38H
RW^#V4OS



M:;XY_HF(

M!8U&]+6#Z3K9FPMS-)S?72BPD_C





M/=CA@


M+8MC)]2^\%4/+^($1&_82NXI9..X*QILO/#7I5XY)
G)G\;(SDMA#VT%Y9^0



M%(

M##
C2BH




#1/GS(N
6PS.76W=&]VY

#@VX

M+
P$=+&X69^1H+


%)8^E!&]6\0:0_


M
U4O@]J=GM'/R/_)@GQN3RV='5KP$IRR3DNWV]UVOYN2%MG0).?EU%393#!
M3 :K$=J_#K;(=2=5J\3P[P

RV$^D

MY




OC



M7Y
';JGJD


M8C//8ZYJ ;HC;F









MP(






MUA2(8

MZAZ


M_$XZXC;W'K5;$MJYZ%[2U-+UG:]BD$'':,1ZC!T@LN/ 3KTZ'Z=*&*Y%H


M
*W56]5F)+E[Q^[5%5J(O@ %%$A];F)PA
-#W(



7
9BN@1\QX8

3#35@P)&@%).\Q!CMW=8EP-;++I(OX1QMGNF@G^Z





=(H=
MQE?J95\O^WK9[_NR'P75$XEIZ_BK\N1

KQ5\U2R7VUUJ^7?[W\]VCY




M

M94 Q1R==.JIV !V!XD(3 +X.[@(II'+RM4A\_;$Y899OQZ4JU2TR6&E*5=/?


7SJWB0Z)0 WK#
M V-UQ

MV'I_8CFE_6:_U;P0P-






J&;P*H&PSAK
567MHM+\//MS6

M*_A!OJE'WN


C?/1S)B/)LQ',ST?5^R.VN\<
M#Q:+HNL[F .;2N\/X=J6?N^ 37^P:@5W&XLSX0[$RY%]#/GY9PQZWI\*B4L





M+GL+_@ X%-
9$$01]!3=PCN%Z=O'N

M32EWX'GB/NI;YDX[I7A&!V\^]O\



M:ER/U=?9$;A]7[S+)-WEAXN#-^UVO]\_CF7=CH@=A?[*'B](;ZNG%M18!_]+

MSJ4I?






'$N

\EVYDM/3'%W
NJ/F[*_S9I6,6H).1S!4N@'-L@6*GROQ,O(Z,P2FC$@2H-H(2#4*+(WP?
M_L;.XC2',.*?'/AN$GP]H_V23+-17Q#Q;L:;94WK4F&_P\__Q]02P
$%

38Q
3
P+GAS9.5=W7/;



MA7%]970ZLB/A+G& C!#Q!0['*

M;8:
!Q=XCB(_?'?T)4*^4NW( ..H. L]&E8)4!2;QKN[N^.[TV/&%T!RTNM^

MW8[BF-WAV,B[BK?G
W[.#[E8\H@GBT'L+O#7*
TBC0_%WI6F=8&H U28


AKRXF5CYL*0


HW6: :42\)C$).)K6W28_JB-

MZ?QN31* ?WQ


JMUJ$C=X!88RHQV(
/65]




MSE944ZMK3F/5Z:)A2ZX[6Q'[ZJ [X-9$B2Q?^N
!4&C/RS72(\NX^?4 34JG
MZIIHL6%25P_HO7S8KDGW6Z[XLK



HM95$G
\
_FY''Z:4Z['X&]PA=6$.9.ES9*$@3R2:?

MFV96Q[-O*[*V[:;-&A8PB :(KW6FS:$XU=H6)Y%AVC2+SSF^.W(Y]DCX^!:+
MBGW-&H-UI
_!7CP++2$B*;?/1
Y92TT/MF?KFP6#/#Q[''N4PY%;/$2$OT=^

))\PXD/&-;%I!UU[
M@E*3@W$:^_9C:X^YF^T[&ILT;2U47*XWGOO
_:S3/-
8JQY_JN(L3.]_Y71Z

RQ5KP0UUNPF;;]9.I]K


VQ5QBOL1EP^

M0EG?-K2(L5CQ#UN(ZXNX3
9*.MWI_J:5MDV69*CZ#&ETH(W7S/-+8GDS8]
M3VW10/XPHO++M&906+.JI'@&:X_F+2)*A/J6%$0D2[TG9CPWX6N(GL'JVT;]

=0P?IX7?9[36.;=(^72[<[N9HMK^ZB;Y^%V=UYS6S<S=$B
M*]
*MV1

@J 20QZR
MJ%M^E]B


M7D70)F_*JJA[V5Y%T%H;EEQ3-E23M

M?H'YDTV+01#Y\H7I-%JM_'7U6\4==T:&-O%)Z' 5Z@D5]^ANB;6Z3_-%YH
M%*K)7)2J[O

DAC4(=




MX[?F\4)Y[JE20]0B!U-E_6SW^X!9Q?N 
5.;4W'Z.]G3E*Y)Q:L&Q66$;]]?


$

38Q
3
P7V-A;YX
M;6SE7%EO&CL4?J_4_S7OG8)+=+HJ85V2JD+BD5=\J
W
(5F=LKNUAZ:^_








M&M% VL75%J.8:Q@I$*Z[&84A);$9E5O 6=$--IIRD/-M)^N@?7VYX_MX84
/
M81G6GJ(Q%BA8


Z6@R4MX(H$Q#L6].OS/X=XJ\U=U:J
!0#GA_X#VU,83BE7-P,OU+J\[X< +3!1EK2=@IRGE6/:&[]^?#!+GO


TWT_P*QOTH1
MOPCH]%&A_X/R2T?^#S75'$NH-&Q9M^RK$RS-/YE_XRHE[\^DT/'DDFYQBBI)


G2M#-K-:.\UG#B+[[F86_]Q5


#$V
3$S
M




M


%[WT
MDI@D41B@# ?W&?TO6YJ'H]X$Q6-


T.V):

IOQ*A1QP5W_;$C;WCA:H@.'Y@
MZX4.MT5#K[

M48**2-M\D$2RO#5PO(O-6[LUD*IF!]LHK81R!JV;)&9K
E4+[7I
#V@XQ22[
MKI@/.*#)R+S?K&#&








ME6A\Y*-Q5'6AFW&JUXM3VONE

1& ?WV'&96?G4\

*+0=


KVL^+C(AG)DNAM%Q9'LR!)/)G6@W=IW]QBL_

M*WB*HN+P((VQVVD-&L+0Q)3 E\$=1'H)R8:CXNAVGT0R@_162]BHA&96G1T!
MW/$5[PAT2P^']!=HC#M24

_3UD


!JF _

$_PCS#%]R=AT1


MS(?&:B+,-O-=X9O\F9A)\V_Y9UFOFLYN[:4)5-KY$Y?HL'*84G6L/?\4XA
M#98V1I U-;D3
U4(]BH18KM6IDF?B&=PII/;8^MDRIR)WGNIM;!KFG




*;!E?
]N-9GI&+
J(7<[4T+U\F6&?7K;_2%A4?A1F<\7@V
/7
MO;

I'O;


2?04SO-&L:DKX%J
%_SC88OL&
MZYM@I+UX9V_5O%93:M! &]T:[RH+1T3-TGQB TN_WZ5I

6AD@

M*.'K?GQ*3U9%+J!^)TX]7%439_ZPJ26[.RF?F\PI$\QV&T._955/ZVKDW'OM
MJC5 CN3]V4+*O?*+%_1\Y=.^E66XJ@U!W\+BSP'!+7R;;7MYEZR@%]VQXPQ%
M_7A



)4
M$E772ZE!+* Q4;]P3X;8W@DZ AK\4V!Y?=8O*)H^=UH OMZ3,-%=XM_=^I,
MT&W QS@@5U12MA&06S17N,-%)+!OS#2?$C)YWG9L QS85%4=UB:N;K5$O8A

M]NGM
Z8?F)?VT.!KD@2R Z:



D@%8@C3

M80
:WA3 ZD

XXWV=N*)]Z#FB@CN.)

RKD(D]7M6$ED-7I!B0.MRF*-05S9^+=
MX=G2A3

M:7*0Q.-
2MFNOI2K!W*E-47+*2N?'1+6L<EK#)F/7QDD@


M/\Y0/&9L=0G!&? #/U=

#S^37Z

M
:[9$W3F;4V\:H


EO'9]/Z=W(A;:OQFQV@Q2




I/4)I.U!JKJTNM1()+%H@+X(4^S3



G.80#_&*%;@UHA6


:M
P^6VAWW 5S8UM!#ZE6C;9@_YE5+[*Z7V;:34EG]:!CXM
MM/*D^R*7D #.6ZB74BMC7.X05/W9YP9XGA-ZW2&DZ__




\P1=XKMDYR7/
MZ


-F/WM(\)H_AC!)


MO
9)$/L7D=U0#WJ/.N;;S$NR#J-N]!]IW

M*$)L-Z=USQ['FK7':3R1]0Q234W_/B??WQL9_ISAR
=^.3;:4Z(M&6&F99GR






MW/




4NHW=7=(-@KK:DU.UF *LR'=GO1#K-D%Y1]3HZ::TUE5





7Z
7BQO


C4B*'P1F%1Q'X[9$ET8Y?#S]LX8RE#
M2:V#C)O&$X@S+WV81C[]X^*/7?#HA60TZ30[\Y+D.8CN?_;G?;!IAE1:..A

Z+CL5K%.S*.&[S9$QW
M(;[6:'\M?T/&0TP-T0.K.6-%

-)QR'G1'[IRAX?&.ECWA
M



I'
M4@



Z* W




MGHYS43KYYF^3-V\=$@3-M(Q7U(.A#PR[7Y4F^G=/9SHVQ.[6_TM##L1[J\



R$RE[HJT:_<HOTM1/&S H@!TU_8'@5X('!
M@)ED?1F3FF1M 8

MI]18&\EF;\JDC

M:8OQU@Q$1U@(BLS#
!&U\5QY&A
VB](L82O]




K(P'W9D@&

0P;O )Z.



MA!






M:

*7)'
M-C.Q3;I

B'=6[8'1(S=!\VF.T4

A6KK$JGWU%(D(SI..)




3@7;/1- .N;9*(5R]




MJ[.Z'=%LI*7#6DVVAF;:3+* (-D*/K!*?;J*K-W1@;P$%019
@+T*6_F1BE4

M+7NCPZ)P1=W
C(Z@MRO%VX2
UR[8YI0-TL;QDDJ9&1@E*5N-&E7+N12Q
TQ2
M6M!V20&4$U[+NS-UTR:98Z-W@ZK[8'![I



M]B*+/
H)H)S)^=

M@@N

 W155=:UR8.[4J83H6)




+



;6B:VC\94RS6=#CG


\+-FX).X



NZY


M

+7^4.2/5RJ/\;0AT=XKC/WTDH^
)%&Y-!$7LYX C:<+\R;\[&






M+RI2KD\C_QRGJR38Y@G83W=I$.'4^+5G#!H'23#*3CDJ&9W1/JC!@%Z3E.2
M Z9VM-*Z2A=V_4?


VZWM!G__EQ=CY;_NK =;C6@!OWW8V[KL9]=T7%D0MLL0(3^F%
MW-]!$


9B.4#1H1\0&S#?DA$
M%1A&7[
4Y1\=L10:@B0V&6HI&C
95)V:;TE&E=)WKQTR%BOI09\4:0#FQBU6
M64.;G5PT1*8KJW5XI+FL\'Q[7FD0XW



SXM!.L^E4'/)IV9\=
M$]844$[BA7C95OR@Y7S;







DPZ?:IDD#28=3_HNO0B5I%6FKI]\!*L%DNVE&1@3)5:GBM^X:B!ZVL

MU#]T1C2'0][HX9Y5-.%F/?-HP

M- SC)X_


CP

MT6/;%J^[(\]C3PQG



MRJKIPVTS9MT3E9EE65_G39P]Z(O--HR?
4:W&6EP=.JE#'1-SAD3:
C'4D-H


MF[%\

PYN&9=[<+O813J14WT#J2)-=0.
6I
-

M'4Y
]:B$$K0&E8)LN9ZT
2I:3Q!K/T&D!_J4]S'SN7L9HZWW[E! O2WO&'G'


1.@E2L1(3@M;(

(17T!HW
MXX$1
@)I!



ML!&N^K?TSBV+
R]$B:/'!3J\:7=
W&;
+AY


TN$3V.7C''N$(
@X<\^[-A%KM]!M)




1#FO6_^OGF*1UN:@E-)SNH'+#A2
Y0IG#

!7UAS*H02/NHM6R)BJ8H

GR=:'T=.1!52
M+_'KI(/=8!UYB7)LTQW&1SG'=!RZ]RT!91;FX^HG0W*ZR*]3^*T__1U]@$G
MAG L5(1CI\-\UK0X)^;R91?#_^@%(;W?H,7(+PDT6F@T);TU-]+B[C#F7P:G
MQ59E8\1JT-/FJ&H/[@78(5E1))1%R;YK*06UM

XAR?5\'=
M1^J*657*E




91T*EX0F#



-ZZ2ZR



V#-:9^PJ_8:Z=N@=UU


M








M-D

M+OTE)AOBQH\=R;VMP;SBY-MJSAW/$3D+O32MAK)(;JC#U-@'F[H32GK03H$&
MX-8K0]J%



E+83IDASS-_00:Z2!


MWTQ:6\Q.


.%4IJ.Q4&UY0'Z0KC1M!!V0BR$GG?
S'&48--
ME&I?^



/D0
M[U+BADPC?UEDY&#EY.@G/V=<O(6%$%V+*:@#UFL[(\( 5120(0$*FD@1@0Q
M7OR4TX$ME=
G[B]3&O7^MH'1@:U*5VR-C4K0N*+W[LBN! F!.[)/L9)B\2[%
M1H3'



2%H12^#V&+UHFWA9N2MP;S(WF#E:(JDA
[9
24/:MDT%0..
M)U




MFZT7/3L2)R41%'$TE%A*NA2K7

M6KEEEBQ!./145&OP4EEN(CN09$@I-A('3,L%Z .,OW!2W[_,0[)9-V96&%.
M-Q CS!U^RRLCC5#9RB$3;#YX!PRPUJE
KN_'.X(K1:7*RVO4#)&S-M#'V3&
$)II@ Z(91 .F0<5@S5+5SRQYU .+0QE$3



U

U=T68

1):X(3U-G&H8D+@



P\B/

MW3(VZ7)3ET
'VS'D*6W21L+RG[UP9U9

4X;F:C0+J6S<1IZJ]^/;E</!$2*-K&/&]$5


M9]'S59




R\





!-0)GQP65P)RW9WGZR

JP_W-
4QJ'0?8L
MD+_QU*)@2'\IET
X[2.Z'^484#V(852.

M
F28ECC9F-UU#C
^XU'5E7;/[
B#N9Z64Y%









M0T$/AB!G



M8 I/18IN3I@H.RC3U2K9$=U1G5_AS_0M&Z;[1&K
X@C=$LE@UP;HS=\FB/*+
M

M SXUL9]_$QNAL9!COI1O#H%\31#8)7B]R^L
]SZ=#Z7]M'R/X2:(M@4
YS*8
M6AT]*%L40+X2AFLIDF7PR8#K.R$\36X##


[PW'H9D
;AFMR;

M4N'I3:Y)4VL+W.P

JX

MII9
J^XVL_(3NSC
M#JADJ@&GZ.AH&8]!N9W6A_DB

M6T@%]NNAL0HKZ8SMG[7K*QE2A5+MQNY;%M3F**QE[CIP,F@US*%_)=T;
M[K.B@'86KWXO;$2.GU]2&\3B=08YO;]/\#V]EH$K%-Z'=.F80RN!'?^MU$7^



&T*:4]RTW(L\1.\K+K:0[







20/
MK=[-I\.


4J

M@\1




T7;EU

18@0O+;HCA\B=*C

IRNBQ'=



MZ?N;BXL/%U=+1_;

M^'

:;(RH!EB3_8#DIAO0




57=VY4.D'YZNF'@JB'&L\
M$%9[?\D.K-A=BC-0F33D++E;N)VS%TRD&UMZ0OO@

MSK+:SA*D4AH=^


:W7MK4()^%B\%


A^&\1.O[*;VMH=#RID]



MR DJ4KR*WC#O-B5@.)O+HJT#^79[@R*

W3G=I
M$.$TG:[^V 5IP$Z'-

M F!6%5F?(+3#H@-9AQTGJ.SF7GUEX^75\@ATU[;+\QYZ(\^.6=\G\6X[BTRJ
M
@L[PSSC$4-I5U




(HSZ_3TV7@_TR8\P&R0GZ]#Z#&%R8H_P:J/H+RK[ M2/D=!YY/


3Y*/?Q

MX-YR/8*_P!P?!!2UGF-4


N51[BZYJ


M/[6G

MM'G]WUJE21?%T%4UX-4N;( IV6\@OIEM69'6Z6@.Z).*J'Z*KB-#H^K!X4

M  !T9&YT+3(P
38Q
3

M-KM%W;RL(XDJB8XWGU 0

X_?_[\(?M7

MEGW^EV2S1K^^(\%J';)A9[];8C3_]5WB1PFE/__Q_/SB(Z/^CYUXQI%_$R5!
MLIE$\QBOLC&_.V/]?GV:[ =/HOGK!_;+#U*Z#\W&=!5') X#WTV0?^F&C/O/







VCA9
M&.B]!KF]4T=$CQ*^]MCDA)9/)/HL4UV=%K1'Y]F#_;V)8TEC=/:RO<3UJ/^







BTPM

Z$
M@FIL?^T4 K1O@XB.(Z!

E%T(1
M^A?.*+XYPGCK_I:

M\H0\1*&RJ'R4;%DEF\\2
B G3$UI*Y(_9&4DZ*L1:GE?$D8@%@
=Y09!*9

MS- ]*P$YC.HNID=#%_M

 -ZKZZ?5JF?U
M$T!Y\C0E
M);^J5J$
1;0XI0.ML$8N73X-E


71\'W9V[6LGI)# @C6#N7!4.'
M'-PP;DJ%!P/*((RCILX(.F)**A[1^EL%

B7P?1#'.8F/IYH^(;-$^;NJ
8*U8M63+ S$




MPC!;9Y2!P




M0=ZV*\&D(LDH@PCV
 ;A
!6\X%3*54K7E9A0
QFK( W#P7K\T$\I:3Y!5\(\
MS40LQ#*


M(I*)MN9P^\,.CG\298;,?1AA!_K;-S?7(S=*%$^43;NSH+_4F//Q7D0\B
M;1H




M@XYC$V6R9;D8Z3V5)7-FV4TXNL1M!QQLV):0RBHA0CZ
E2C/NIE);CIG*'?I

MA3SVLCV74&ZCX%7QA%&''#Z?AX%0=16#W,027FJ6.GQ:^T&ODZ^)3EI]Z)

M/(N&'X.'K7J6JR!?1CFNR=ZWMML(P**5?:8R5*B0C(RZ,A0BR+FZY *_"N
M3I1]'D(^N:7\?8@3M-O=Y3YH+@ETH&?KB$#/KQEXGD9XV2&\
I@C2C10




;.&17.)?WX'[(3NU8'P(E7IP7G=9U
M@?5P-MT%?Z:!;U094+'['M2;125AD;*KOJZ3%



M$/.
0B
4NYG2VHHRY8]#XXBA(@4X:(B&Q&R@84SH(57GM&'0_10T
$@H.'





M
!B(*!
MKEI10R$D4*#?:K7C7[H-HB!!=\$K\I6+A9(6NM9$+8&K
5FK=0PYK5=K-\#9
M6T9\'9!U3-QP.K^+HT6&-0=O


MBEB2@@7=[8RL2$I:Z&H/]:X!&J#VPN^[]9 DT_DSO3V;V!2$1- 5&.J9#F5H

D#9% 4Q4P]Q=+-:A_$&H2S-






7Q#^;)8'GQI[=_
ME!6Y


!XDU$26OHL%@382E@6'M5;5-&NP%N=P*1

WYKSYM/YJ#=5S?(G4+




L;=TR2''LL:J)2


0


MD#^F&XR[0+L3VR
./
3D-#^EZ5=S


J.V-5OLC0+ZD7&O9HQ=


I'*HD*Z.*%#*+ET)D_/5- U '

M0:9MR)_BWY TAZT6-63&+[OSKX0)^@)N(M$K-_)0&++Q9S'DAB*MDD.F$[
D






_=4/%X8W;'CP_0_OG.%N:VXQF+-








MX

M?M3Y-'23;VMLVRMTOTV\XU6
.*B(2/G$

$O%Q16!- -V4WIB/.


E]\

/+<K77EY4RSVY<;0E;1J% .!C97UM#?CP!7YVHPW2T@MQ8LT#75*CTH

M'$&P=BT'G
ETZ_
0\LDM91+;_
BCNU'X\T4DT7&&LQ'&21K1_FZ4\Z2H/,P
M(1;#]H2D+\V/6D+7%FLBUBH2Z/I&=H19U-$?]C)@^TLP3Q _E6*L5S0!KU

Y%\[

C!+XS7JL!V&.YX(67ZW:%P(M-.9) J0E4#(U 68HL+4
1


BRK;I;UJAB[=)WB
M?=9MB;1-NH$.TS94 $-HT%NMK1C0]=9C-IUK.H-%)-!VJ;REN'H:'J/7=A1
M.011^'1,T!PZ+%M74H

M579*3FL@\Z2C8*5AS_^CAD]:CQ.A;4HKC*65..1]U5SIN]/(6Q_?$9*F-Z



M/@&P-5$D&SU)[B'TV_55.#LQ9
IT
MSVP#9$L6CXHA1A&

M\Z'1
BN&8

M-<$#BUTQH:&X  D;47HYT1^SU;R=@C('D90S$1=(*'AH(^AF+M?6A'
M[O@]3_30Z'8O2N_0^
EG+=F*G+Z^'^2CN$TC/X@60D.;K#ETY@9M.:E '
PO




*V[3Y4@?$(

M*B


MHJFJ0PL=OZLM%\Z\UL77Q6L/&RU*
G?
='X5TQL;'6+&?'$XAQXA=+1N$XEJ
;1OZ+=ER29
MA=<[I/*HZ]D6V:$$GU&EG5+1&7FC#<<F\BBKB2 S3&EPC&LT4^#IF%VS-QFG
M])BK-.C_E7CJK\13;(#7/GT(DI(L(@R+'H6?059]Y-.J0%TR.[6KET?YOA=
W1 1:28.:7L@QZ4^WSGRDF!SKDN.L %&'ETT&0=1P1EPWYKRA*
MD5IR.K107M-&8M0%!FN6;2#1:T0\'*P%9K8ZW4Y3UN7\Q%&:&NLX:++6DZC


H2MWP/HB5;KZ0F]S;I0@Y#_%&S=,-D)+IY0*RFO:
M2+IJ2-:2VU0DF+WC;$^*DXA2_%1/ECDM5!*;%B5Z &8MI8W=F;D=Y^$JC_*

0?6SF
3AB6
(F\

(S?L@1*!G*N4H/7.K
B


MG'OEH2BSZW&: T\)3,%\T$ HM_YK(Y!;92%; 44T$GO!,+1$^4!P^DJ4Q:


M2OJXW9^&S\[R9-NO2/O!F8  

VT?W4U6)6$6;T\YN_

8I<2F]T5STV!P  <E<  !4              ( !O9@
M '1D;G0M,C Q-C$Q,S!?8V%L+GAM;%!+ 0(4 Q0    ( 'F*7$KBV*]01D
M $6/ 0 5                2:@  !T9&YT+3(P,38Q,3,P7V1E9BYX;6Q0
M2P$% 
4     !YBEQ*Z9GH1=%.  #PK00 %0              @ &:N0
M=&1N=TR
#$V
3$S


